# Cytokinetic abscission requires actin-dependent microtubule severing

Tamara Advedissian, Stéphane Frémont, Arnaud Echard

► To cite this version:

Tamara Advedissian, Stéphane Frémont, Arnaud Echard. Cytokinetic abscission requires actin-dependent microtubule severing. Nature Communications, 2024, 15 (1), pp.1949. 10.1038/s41467-024-46062-9. pasteur-04534655

HAL Id: pasteur-04534655

https://pasteur.hal.science/pasteur-04534655

Submitted on 5 Apr 2024

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
# Cytokinetic abscission requires actin-dependent microtubule severing

Tamara Advedissian, Stéphane Frémont, Arnaud Echard

► To cite this version:

Tamara Advedissian, Stéphane Frémont, Arnaud Echard. Cytokinetic abscission requires actin-dependent microtubule severing. Nature Communications, 2024, 15 (1), pp.1949. 10.1038/s41467-024-46062-9. pasteur-04534655

HAL Id: pasteur-04534655

https://pasteur.hal.science/pasteur-04534655v1

Submitted on 5 Apr 2024

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
<figure><img src="image_2.png" /></figure>

# Cytokinetic abscission requires actin-dependent microtubule severing

Received: 22 May 2023

Accepted: 9 February 2024

Published online: 02 March 2024

<figure><img src="image_3.png" /></figure>

Check for updates

Tamara Advedissian<sup>1</sup>, Stéphane Frémont<sup>1</sup> & Arnaud Echard<sup>1</sup>

Cell division is completed by the abscission of the intercellular bridge connecting the daughter cells. Abscission requires the polymerization of an ESCRT-III cone close to the midbody to both recruit the microtubule severing enzyme spastin and scission the plasma membrane. Here, we found that the microtubule and the membrane cuts are two separate events that are regulated differently. Using HeLa cells, we uncovered that the F-actin disassembling protein Cofilin-1 controls the disappearance of a transient pool of branched F-actin which is precisely assembled at the tip of the ESCRT-III cone shortly before the microtubule cut. Functionally, Cofilin-1 and Arp2/3-mediated branched F-actin favor abscission by promoting local severing of the microtubules but do not participate later in the membrane scission event. Mechanistically, we propose that branched F-actin functions as a physical barrier that limits ESCRT-III cone elongation and thereby favors stable spastin recruitment. Our work thus reveals that F-actin controls the timely and local disassembly of microtubules required for cytokinetic abscission.

Cytokinesis concludes cell division and leads to the physical separation of the two daughter cells following chromosome segregation. After complete furrow ingression driven by an actomyosin ring<sup>1,2</sup>, the daughter cells are connected by an intercellular bridge (ICB) filled with microtubules (MTs). At the center of the ICB, an electron-dense structure named the midbody is a major platform which recruits all known proteins required for cell separation also called abscission<sup>3-5</sup>. In particular, the ESCRT-III (Endosomal Sorting Complex Required for Transport III) machinery<sup>6-10</sup> localizes at the midbody, and highly dynamic ESCRT-III filaments polymerize as a cone-like structure extending from the midbody to constrict the ICB membrane until the final cut<sup>11-17</sup>. This site of constriction has been named the “secondary ingression” or “abscission site” or “constriction zone” and is usually located at a distance of 1-2 µm from the midbody<sup>18-22</sup>. Scission of the ICB often occurs successively on both sides of the midbody, releasing a “midbody remnant” that can be later tethered and phagocytosed<sup>23,24</sup>.

Cytokinetic abscission requires a profound remodeling of the cytoskeleton at the ICB. Notably, both MTs and actin filaments (F-actin) must be removed to allow the ICB cut since the presence of these cytoskeleton elements would prevent local membrane fusion<sup>16</sup>. In addition to mediating membrane scission, the ESCRT-III machinery

contributes to the clearance of MTs at the secondary ingression by recruiting the MT severing AAA-ATPase spastin through direct binding with the ESCRT-III subunit CHMPIB<sup>13,25-27</sup>. In parallel, several pathways control global F-actin levels within the ICB by either limiting F-actin polymerization —through RhoA inactivation by p50RhoGAP or PtdIns(4,5)P2 hydrolysis by OCRL1— or triggering F-actin depolymerization —through actin oxidation by MICAL1<sup>19,28-32</sup>. While many studies demonstrated that global F-actin disassembly within the ICB is critical for abscission, it remains unclear whether F-actin might also play, likely locally, a role in abscission. Indeed, depending on the studies, experimental depolymerization of F-actin after complete furrow ingression using drugs led either to no effect, or to ICB instability followed by the formation of binucleated cells or to abscission defects<sup>13,14,33,34</sup>. Importantly, if F-actin is required for abscission, it remains to be discovered why at the mechanistic level.

Here, we found that the F-actin disassembling protein Cofilin-1 participates in cytokinetic abscission by regulating a transient pool of Arp2/3-mediated branched F-actin at the secondary ingression. These findings thus reveal an undescribed function of Cofilin-1 in late steps of cytokinesis, long after furrow ingression during which Cofilin-1 is well known to favor F-actin turnover<sup>35-41</sup>. Cofilin-1 and Arp2/3 promote

<figure><img src="image_4.png" /></figure>

<footnote n="1">¹Institut Pasteur, Université Paris Cité, CNRS UMR3691, Membrane Traffic and Cell Division Unit, 25-28 rue du Dr Roux, F-75015 Paris, France.</footnote>

<footnote>e-mail: arnaud.echard@pasteur.fr</footnote>
<figure><img src="image_2.png" /></figure>

# Cytokinetic abscission requires actin-dependent microtubule severing

Received: 22 May 2023

Accepted: 9 February 2024

Published online: 02 March 2024

<figure><img src="image_3.png" /></figure>

Check for updates

Tamara Advedissian<sup>1</sup>, Stéphane Frémont<sup>1</sup> & Arnaud Echard<sup>1</sup>

Cell division is completed by the abscission of the intercellular bridge connecting the daughter cells. Abscission requires the polymerization of an ESCRT-III cone close to the midbody to both recruit the microtubule severing enzyme spastin and scission the plasma membrane. Here, we found that the microtubule and the membrane cuts are two separate events that are regulated differently. Using HeLa cells, we uncovered that the F-actin disassembling protein Cofilin-1 controls the disappearance of a transient pool of branched F-actin which is precisely assembled at the tip of the ESCRT-III cone shortly before the microtubule cut. Functionally, Cofilin-1 and Arp2/3-mediated branched F-actin favor abscission by promoting local severing of the microtubules but do not participate later in the membrane scission event. Mechanistically, we propose that branched F-actin functions as a physical barrier that limits ESCRT-III cone elongation and thereby favors stable spastin recruitment. Our work thus reveals that F-actin controls the timely and local disassembly of microtubules required for cytokinetic abscission.

Cytokinesis concludes cell division and leads to the physical separation of the two daughter cells following chromosome segregation. After complete furrow ingression driven by an actomyosin ring<sup>1,2</sup>, the daughter cells are connected by an intercellular bridge (ICB) filled with microtubules (MTs). At the center of the ICB, an electron-dense structure named the midbody is a major platform which recruits all known proteins required for cell separation also called abscission<sup>3-5</sup>. In particular, the ESCRT-III (Endosomal Sorting Complex Required for Transport III) machinery<sup>6-10</sup> localizes at the midbody, and highly dynamic ESCRT-III filaments polymerize as a cone-like structure extending from the midbody to constrict the ICB membrane until the final cut<sup>11-17</sup>. This site of constriction has been named the "secondary ingression" or "abscission site" or "constriction zone" and is usually located at a distance of 1-2 µm from the midbody<sup>18-22</sup>. Scission of the ICB often occurs successively on both sides of the midbody, releasing a "midbody remnant" that can be later tethered and phagocytosed<sup>23,24</sup>.

Cytokinetic abscission requires a profound remodeling of the cytoskeleton at the ICB. Notably, both MTs and actin filaments (F-actin) must be removed to allow the ICB cut since the presence of these cytoskeleton elements would prevent local membrane fusion<sup>16</sup>. In addition to mediating membrane scission, the ESCRT-III machinery

contributes to the clearance of MTs at the secondary ingression by recruiting the MT severing AAA-ATPase spastin through direct binding with the ESCRT-III subunit CHMPIB<sup>13,25-27</sup>. In parallel, several pathways control global F-actin levels within the ICB by either limiting F-actin polymerization —through RhoA inactivation by p50RhoGAP or PtdIns(4,5)P2 hydrolysis by OCRL1— or triggering F-actin depolymerization —through actin oxidation by MICAL1<sup>19,28-32</sup>. While many studies demonstrated that global F-actin disassembly within the ICB is critical for abscission, it remains unclear whether F-actin might also play, likely locally, a role in abscission. Indeed, depending on the studies, experimental depolymerization of F-actin after complete furrow ingression using drugs led either to no effect, or to ICB instability followed by the formation of binucleated cells or to abscission defects<sup>13,14,33,34</sup>. Importantly, if F-actin is required for abscission, it remains to be discovered why at the mechanistic level.

Here, we found that the F-actin disassembling protein Cofilin-1 participates in cytokinetic abscission by regulating a transient pool of Arp2/3-mediated branched F-actin at the secondary ingression. These findings thus reveal an undescribed function of Cofilin-1 in late steps of cytokinesis, long after furrow ingression during which Cofilin-1 is well known to favor F-actin turnover<sup>35-41</sup>. Cofilin-1 and Arp2/3 promote

<figure><img src="image_4.png" /></figure>

<footnote n="1">¹Institut Pasteur, Université Paris Cité, CNRS UMR3691, Membrane Traffic and Cell Division Unit, 25-28 rue du Dr Roux, F-75015 Paris, France.</footnote>

<footnote>e-mail: arnaud.echard@pasteur.fr</footnote>
abscission by controlling the severing of the MTs but not the mem-
brane scission that we found to occur much later. Thus, abscission
requires two temporally distinct events, a MT cut and a membrane cut,
that are regulated separately. Furthermore, our work reveals a critical
and specific role of F-actin in the ESCRT-III- and spastin-dependent MT
severing step required for abscission.

Results

Cofilin-1 and F-actin are transiently enriched at the secondary
ingression

We recently obtained the quantitative proteome of midbody remnants from HeLa cells, that we termed the Flemmingsome²¹. This helped to reveal the function of several proteins in abscission (e.g. Syndecan-4, syntenin, Cavin1, Caveolin-1)²¹,²² and post-abscission midbody remnant tethering to cells (e.g., BST2/Tetherin)⁴². Here, we noticed that Cofilin-1 was found enriched by two-fold in the Flemmingsome compared to control fractions, which suggested a potential function of this actin binding protein in late cytokinetic steps (Supplementary Fig. 1a).

We first investigated the localization of endogenous Cofilin-1
throughout cytokinesis by immunofluorescence in HeLa cells. As pre-
viously described¹³, Cofilin-1 was detected at the cleavage furrow in
71.8% ± 3.4% of the dividing cells (N = 4 independent experiments,
n = 15–43 cells per experiment) (Supplementary Fig. 1b). A thus far
overlooked pool of Cofilin-1 was also present in the ICBs at later stages
of cytokinesis. Cofilin-1 indeed localized at the midbody in
60.6% ± 5.4% (N = 4, n = 22–42) of late ICBs without yet secondary
ingression (i.e. with no pinch of the tubulin staining on the side of the
midbody) (Fig. 1a, top panels). Furthermore, in 71.2% ± 7.9% (N = 4,
n = 15–19) of older ICBs with secondary ingression, Cofilin-1 was
detected at the midbody and/or, intriguingly, at the secondary
ingression itself (Fig. 1a bottom panels, arrowhead). The latter locali-
zation was observed in approximately 30% of ICBs with secondary
ingression (Fig. 1b), suggesting that Cofilin-1 is transiently recruited at
the secondary ingression. We confirmed the localization of Cofilin-1 at
the secondary ingression in primary BMEL (Bipotential Mouse
Embryonic Liver) progenitor cells (Supplementary Fig. 1c).

To reveal the dynamic behavior of Cofilin-1 in late cytokinetic
steps, we monitored HeLa cells that expressed wild type or mutant
versions of human Cofilin-1 tagged with GFP (Cofilin-1-GFP) by time-
lapse spinning disk microscopy. We observed that both wild type and
active, non-phosphorylatable Cofilin-1 mutant (Cofilin-1-S3A-GFP),
exhibited a transient recruitment at the secondary ingression (Fig. 1c
arrowhead and Supplementary Fig. 1d). In contrast, the phospho-
mimetic mutant (Cofilin-1-S3E-GFP), which is inactive and had a lower
affinity for actin⁴⁴⁻⁴⁷, did not localize to ICBs (Supplementary Fig. 1e).
This result suggested that Cofilin-1 recruitment at the secondary
ingression was dependent on the binding of activated Cofilin-1 to
F-actin. Consistently, live cell microscopy in cells that stably co-
expressed Cofilin-1-GFP and the F-actin probe LifeAct-mCherry showed
that Cofilin-1 and F-actin appeared and disappeared simultaneously at
the secondary ingression (Fig. 1d, arrowhead and Supplementary
movie 1). In addition, treating the cells with high doses of either
Cytochalasin D (CytoD) or Latrunculin A (LatA) —two drugs that
depolymerize F-actin through different mechanisms— reduced F-actin
levels in the ICBs and the proportion of ICBs with Cofilin-1 at the sec-
ondary ingression (Fig. 1e and Supplementary Fig. 1f, g). We conclude
that Cofilin-1 and F-actin are transiently enriched together at the sec-
ondary ingression and that Cofilin-1 recruitment depends on F-actin.

Cofilin-1 contributes to abscission by regulating F-actin
depolymerization

To investigate a potential function of Cofilin-1 in abscission, we
depleted Cofilin-1 using siRNAs (Fig. 2a) and used time-lapse phase
contrast microscopy to measure the time it took after furrow ingres-
sion to physically cut the ICB. In our depletion conditions,

approximately 22% of the dividing cells became binucleated (Supple-
mentary Fig. 2a). Consistent with previous reports³⁸,⁴⁰,⁴⁸, a fraction of
binucleated cells arose before ICB formation either from instability of
the ingressing furrow or from mispositioning of the contractile ring
(Supplementary Fig. 2b). We also observed that approximately 40% of
the binucleated cells resulted from late regression of the ICB, a phe-
nomenon not reported before. This often occurred at a time after
normal abscission (i.e. > 250 min), indicating cytokinesis abortion
consecutive to failed abscission upon Cofilin-1 depletion (Supple-
mentary Fig. 2b). Importantly, abscission was delayed in Cofilin-1-
depleted cells that did not become binucleated (Fig. 2b). Transient
expression of wild type Cofilin-1-GFP rescued normal timing of
abscission in Cofilin-1-depleted cells (Fig. 2c and Supplementary
Fig. 2c), indicating a specific function of Cofilin-1 in abscission. More-
over, active Cofilin-1-S3A-GFP mutant restored correct timing of
abscission whereas the inactive form, Cofilin-1-S3E-GFP, did not
(Fig. 2c), showing that Cofilin-1 activation and binding to actin are
required for Cofilin-1 function in abscission.

To rule out that the abscission delay resulted from indirect effects
due to long term depletion of Cofilin-1 by siRNAs, we took advantage of
a chemogenetic method recently developed⁴⁹ to acutely deplete
Cofilin-1 from the cytosol only in cytokinesis and after furrow ingres-
sion. Briefly, we generated a stable cell line that expressed both siRNA-
resistant Cofilin-1-GFP and engineered anti-GFP nanobodies anchored
to the outer membrane of mitochondria (Fig. 2d). After depletion of
endogenous Cofilin-1, removal of trimethoprim (TMP) from the med-
ium activated the nanobodies and thus led to a rapid (<5 min) and
massive sequestration of Cofilin-1-GFP from the cytosol to the mito-
chondrial surface (Fig. 2d), preventing Cofilin-1-GFP recruitment at the
secondary ingression (Supplementary Fig. 2d). Interestingly, acute
depletion of Cofilin-1-GFP from the cytosol, after furrow ingression,
delayed abscission (Fig. 2e, siCofilin-1 - TMP) as compared to control
conditions (Fig. 2e, siCofilin-1 + TMP and siControl ± TMP), similar to
what we observed upon long-term depletion. Thus, acute depletion of
Cofilin-1 demonstrated a function of Cofilin-1 after furrow ingression in
promoting cytokinetic abscission.

To determine whether Cofilin-1 participates in abscission through
depolymerization of F-actin, as expected for an actin disassembly
factor, we treated the cells with low doses of either CytoD (Fig. 2f) or
LatA (Supplementary Fig. 2e). The addition of low doses of either Cyto
D (7.5 nM) or LatA (20 nM) did not perturb cytokinetic abscission in
control cells but restored proper timing of abscission in Cofilin-1-
depleted cells. We conclude that the disassembly of F-actin by Cofilin-1
is important for abscission.

Cofilin-1 controls the local disassembly of branched F-actin at
the secondary ingression just before the MT cut

We next investigated the nature of the pool of F-actin colocalizing with
Cofilin-1 at the secondary ingression and whether Cofilin-1 controls its
dynamics. In fixed HeLa cells, F-actin at the secondary ingression co-
localized with the subunit ARPC2 of the Arp2/3 complex, a major
nucleator of actin filaments, primarily in the form of branches growing
off the sides of other filaments (branched F-actin)⁵⁰⁻⁵⁴ (Fig. 3a, arrow-
head). The presence of ARPC2 at the secondary ingression was also
observed in mouse BMEL cells (Supplementary Fig. 3a). Time-lapse
spinning disk microscopy in HeLa cells further established that the
Arp2/3 subunit GFP-ARPC4 co-localized with Cofilin-1 at the secondary
ingression (Fig. 3b and Supplementary movie 2). Of note, Cofilin-1 and
Arp2/3 appeared simultaneously at the secondary ingression, dis-
played a maximal recruitment 5 min before the MT cut in most cells
and completely disappeared when the MTs were cut (Fig. 3c, time 0
corresponds to the time of the MT cut to allow comparison between
cells and Supplementary Fig. 3b). Both Cofilin-1 and ARPC4 remained
only for approximately 15 min at the secondary ingression (Supple-
mentary Fig. 3c). The localization of another Arp2/3 subunit (ARPC5) at
abscission by controlling the severing of the MTs but not the mem-
brane scission that we found to occur much later. Thus, abscission
requires two temporally distinct events, a MT cut and a membrane cut,
that are regulated separately. Furthermore, our work reveals a critical
and specific role of F-actin in the ESCRT-III- and spastin-dependent MT
severing step required for abscission.

Results

Cofilin-1 and F-actin are transiently enriched at the secondary
ingression

We recently obtained the quantitative proteome of midbody remnants from HeLa cells, that we termed the Flemmingsome²¹. This helped to reveal the function of several proteins in abscission (e.g. Syndecan-4, syntenin, Cavin1, Caveolin-1)²¹,²² and post-abscission midbody remnant tethering to cells (e.g., BST2/Tetherin)⁴². Here, we noticed that Cofilin-1 was found enriched by two-fold in the Flemmingsome compared to control fractions, which suggested a potential function of this actin binding protein in late cytokinetic steps (Supplementary Fig. 1a).

We first investigated the localization of endogenous Cofilin-1
throughout cytokinesis by immunofluorescence in HeLa cells. As pre-
viously described¹³, Cofilin-1 was detected at the cleavage furrow in
71.8% ± 3.4% of the dividing cells (N = 4 independent experiments,
n = 15–43 cells per experiment) (Supplementary Fig. 1b). A thus far
overlooked pool of Cofilin-1 was also present in the ICBs at later stages
of cytokinesis. Cofilin-1 indeed localized at the midbody in
60.6% ± 5.4% (N = 4, n = 22–42) of late ICBs without yet secondary
ingression (i.e. with no pinch of the tubulin staining on the side of the
midbody) (Fig. 1a, top panels). Furthermore, in 71.2% ± 7.9% (N = 4,
n = 15–19) of older ICBs with secondary ingression, Cofilin-1 was
detected at the midbody and/or, intriguingly, at the secondary
ingression itself (Fig. 1a bottom panels, arrowhead). The latter locali-
zation was observed in approximately 30% of ICBs with secondary
ingression (Fig. 1b), suggesting that Cofilin-1 is transiently recruited at
the secondary ingression. We confirmed the localization of Cofilin-1 at
the secondary ingression in primary BMEL (Bipotential Mouse
Embryonic Liver) progenitor cells (Supplementary Fig. 1c).

To reveal the dynamic behavior of Cofilin-1 in late cytokinetic
steps, we monitored HeLa cells that expressed wild type or mutant
versions of human Cofilin-1 tagged with GFP (Cofilin-1-GFP) by time-
lapse spinning disk microscopy. We observed that both wild type and
active, non-phosphorylatable Cofilin-1 mutant (Cofilin-1-S3A-GFP),
exhibited a transient recruitment at the secondary ingression (Fig. 1c
arrowhead and Supplementary Fig. 1d). In contrast, the phospho-
mimetic mutant (Cofilin-1-S3E-GFP), which is inactive and had a lower
affinity for actin⁴⁴⁻⁴⁷, did not localize to ICBs (Supplementary Fig. 1e).
This result suggested that Cofilin-1 recruitment at the secondary
ingression was dependent on the binding of activated Cofilin-1 to
F-actin. Consistently, live cell microscopy in cells that stably co-
expressed Cofilin-1-GFP and the F-actin probe LifeAct-mCherry showed
that Cofilin-1 and F-actin appeared and disappeared simultaneously at
the secondary ingression (Fig. 1d, arrowhead and Supplementary
movie 1). In addition, treating the cells with high doses of either
Cytochalasin D (CytoD) or Latrunculin A (LatA) —two drugs that
depolymerize F-actin through different mechanisms— reduced F-actin
levels in the ICBs and the proportion of ICBs with Cofilin-1 at the sec-
ondary ingression (Fig. 1e and Supplementary Fig. 1f, g). We conclude
that Cofilin-1 and F-actin are transiently enriched together at the sec-
ondary ingression and that Cofilin-1 recruitment depends on F-actin.

Cofilin-1 contributes to abscission by regulating F-actin
depolymerization

To investigate a potential function of Cofilin-1 in abscission, we
depleted Cofilin-1 using siRNAs (Fig. 2a) and used time-lapse phase
contrast microscopy to measure the time it took after furrow ingres-
sion to physically cut the ICB. In our depletion conditions,

approximately 22% of the dividing cells became binucleated (Supple-
mentary Fig. 2a). Consistent with previous reports³⁸,⁴⁰,⁴⁸, a fraction of
binucleated cells arose before ICB formation either from instability of
the ingressing furrow or from mispositioning of the contractile ring
(Supplementary Fig. 2b). We also observed that approximately 40% of
the binucleated cells resulted from late regression of the ICB, a phe-
nomenon not reported before. This often occurred at a time after
normal abscission (i.e. > 250 min), indicating cytokinesis abortion
consecutive to failed abscission upon Cofilin-1 depletion (Supple-
mentary Fig. 2b). Importantly, abscission was delayed in Cofilin-1-
depleted cells that did not become binucleated (Fig. 2b). Transient
expression of wild type Cofilin-1-GFP rescued normal timing of
abscission in Cofilin-1-depleted cells (Fig. 2c and Supplementary
Fig. 2c), indicating a specific function of Cofilin-1 in abscission. More-
over, active Cofilin-1-S3A-GFP mutant restored correct timing of
abscission whereas the inactive form, Cofilin-1-S3E-GFP, did not
(Fig. 2c), showing that Cofilin-1 activation and binding to actin are
required for Cofilin-1 function in abscission.

To rule out that the abscission delay resulted from indirect effects
due to long term depletion of Cofilin-1 by siRNAs, we took advantage of
a chemogenetic method recently developed⁴⁹ to acutely deplete
Cofilin-1 from the cytosol only in cytokinesis and after furrow ingres-
sion. Briefly, we generated a stable cell line that expressed both siRNA-
resistant Cofilin-1-GFP and engineered anti-GFP nanobodies anchored
to the outer membrane of mitochondria (Fig. 2d). After depletion of
endogenous Cofilin-1, removal of trimethoprim (TMP) from the med-
ium activated the nanobodies and thus led to a rapid (<5 min) and
massive sequestration of Cofilin-1-GFP from the cytosol to the mito-
chondrial surface (Fig. 2d), preventing Cofilin-1-GFP recruitment at the
secondary ingression (Supplementary Fig. 2d). Interestingly, acute
depletion of Cofilin-1-GFP from the cytosol, after furrow ingression,
delayed abscission (Fig. 2e, siCofilin-1 - TMP) as compared to control
conditions (Fig. 2e, siCofilin-1 + TMP and siControl ± TMP), similar to
what we observed upon long-term depletion. Thus, acute depletion of
Cofilin-1 demonstrated a function of Cofilin-1 after furrow ingression in
promoting cytokinetic abscission.

To determine whether Cofilin-1 participates in abscission through
depolymerization of F-actin, as expected for an actin disassembly
factor, we treated the cells with low doses of either CytoD (Fig. 2f) or
LatA (Supplementary Fig. 2e). The addition of low doses of either Cyto
D (7.5 nM) or LatA (20 nM) did not perturb cytokinetic abscission in
control cells but restored proper timing of abscission in Cofilin-1-
depleted cells. We conclude that the disassembly of F-actin by Cofilin-1
is important for abscission.

Cofilin-1 controls the local disassembly of branched F-actin at
the secondary ingression just before the MT cut

We next investigated the nature of the pool of F-actin colocalizing with
Cofilin-1 at the secondary ingression and whether Cofilin-1 controls its
dynamics. In fixed HeLa cells, F-actin at the secondary ingression co-
localized with the subunit ARPC2 of the Arp2/3 complex, a major
nucleator of actin filaments, primarily in the form of branches growing
off the sides of other filaments (branched F-actin)⁵⁰⁻⁵⁴ (Fig. 3a, arrow-
head). The presence of ARPC2 at the secondary ingression was also
observed in mouse BMEL cells (Supplementary Fig. 3a). Time-lapse
spinning disk microscopy in HeLa cells further established that the
Arp2/3 subunit GFP-ARPC4 co-localized with Cofilin-1 at the secondary
ingression (Fig. 3b and Supplementary movie 2). Of note, Cofilin-1 and
Arp2/3 appeared simultaneously at the secondary ingression, dis-
played a maximal recruitment 5 min before the MT cut in most cells
and completely disappeared when the MTs were cut (Fig. 3c, time 0
corresponds to the time of the MT cut to allow comparison between
cells and Supplementary Fig. 3b). Both Cofilin-1 and ARPC4 remained
only for approximately 15 min at the secondary ingression (Supple-
mentary Fig. 3c). The localization of another Arp2/3 subunit (ARPC5) at
<figure><img src="image_5.png" /></figure>

<figure><img src="image_6.png" /></figure>

<figure><img src="image_7.png" /></figure>

<figure><img src="image_8.png" /><figcaption>**Fig. 1 |** Cofilin-1 and F-actin are transiently enriched at the secondary ingres-
sion. **a** Staining of endogenous Cofilin-1 and α-tubulin + β-tubulin + acetylated
tubulin (hereafter Tubulin) at indicated stages of cytokinesis in HeLa cells. DAPI:
4',6-diamidino-2-phenylindole. Bracket (here and in all Figures): midbody (MB).
Arrowhead: Cofilin-1 at the secondary ingression. Scale bars = 10 µm. **b** Percentage
of ICBs with secondary ingression positive for Cofilin-1. Mean ± SD, *n* ≥ 15 cells per
experiment, *N* = 3 independent experiments. **c** Snapshots of a spinning disk con-
focal microscopy movie of cells stably expressing Cofilin-1-GFP and incubated with
fluorescent SiR-Tubulin. Arrowheads: Cofilin-1 at the secondary ingression. Scale</figcaption></figure>

<figure><img src="image_9.png" /></figure>

bar = 10 µm. d Snapshots of a spinning disk confocal microscopy movie of cells stably co-expressing Cofilin-1-GFP and LifeAct-mCherry and incubated with fluorescent SiR-Tubulin. Arrowheads: Cofilin-1 and LifeAct co-localization at the secondary ingression. Scale bar = 5 µm. e Top: Staining of endogenous Cofilin-1 and Tubulin in late ICBs with secondary ingression (arrowheads) in cells treated with either DMSO or 0.4 µM Cytochalasin D (CytoD) for 1 h prior to fixation. Scale bars = 10 µm. Bottom: Percentage of ICBs with secondary ingression positive for Cofilin-1. Mean ± SD, *n* ≥ 19 cells per condition, *N* = 3 independent experiments. Two-tailed unpaired Student's t-test.
<figure><img src="image_5.png" /><figcaption>b</figcaption></figure>

<figure><img src="image_6.png" /><figcaption>c</figcaption></figure>

<figure><img src="image_7.png" /><figcaption>d</figcaption></figure>

<figure><img src="image_8.png" /><figcaption>e</figcaption></figure>

<figure><img src="image_9.png" /></figure>

**Fig. 1 | Cofilin-1 and F-actin are transiently enriched at the secondary ingres-
sion.** a Staining of endogenous Cofilin-1 and α-tubulin + β-tubulin + acetylated
tubulin (hereafter Tubulin) at indicated stages of cytokinesis in HeLa cells. DAPI:
4',6-diamidino-2-phenylindole. Bracket (here and in all Figures): midbody (MB).
Arrowhead: Cofilin-1 at the secondary ingression. Scale bars = 10 µm. b Percentage
of ICBs with secondary ingression positive for Cofilin-1. Mean ± SD, n ≥ 15 cells per
experiment, N = 3 independent experiments. c Snapshots of a spinning disk con-
focal microscopy movie of cells stably expressing Cofilin-1-GFP and incubated with
fluorescent SiR-Tubulin. Arrowheads: Cofilin-1 at the secondary ingression. Scale

bar = 10 µm. d Snapshots of a spinning disk confocal microscopy movie of cells stably co-expressing Cofilin-1-GFP and LifeAct-mCherry and incubated with fluorescent SiR-Tubulin. Arrowheads: Cofilin-1 and LifeAct co-localization at the secondary ingression. Scale bar = 5 µm. e Top: Staining of endogenous Cofilin-1 and Tubulin in late ICBs with secondary ingression (arrowheads) in cells treated with either DMSO or 0.4 µM Cytochalasin D (CytoD) for 1 h prior to fixation. Scale bars = 10 µm. Bottom: Percentage of ICBs with secondary ingression positive for Cofilin-1. Mean ± SD, n ≥ 19 cells per condition, N = 3 independent experiments. Two-tailed unpaired Student's t-test.
<figure><img src="image_10.png" /></figure>

<figure><img src="image_11.png" /></figure>

<figure><img src="image_12.png" /></figure>

<figure><img src="image_13.png" /></figure>

<figure><img src="image_14.png" /></figure>

<figure><img src="image_15.png" /></figure>

<figure><img src="image_16.png" /></figure>

<figure><img src="image_17.png" /></figure>

<figure><img src="image_18.png" /></figure>

<figure><img src="image_19.png" /></figure>

the secondary ingression and its disappearance at the time of the MT cut were confirmed in mouse 3T3 cells (Supplementary Fig. 3d). Of note, Arp2/3 can nucleate linear actin filaments upon activation by SPIN90⁵⁵. However, we did not detect SPIN90 together with Arp2/3 or F-actin at the secondary ingression (Supplementary Fig. 3e). We conclude that the F-actin that transiently accumulates with Cofilin-1 at the

secondary ingression (Fig. 1d) likely corresponds to branched actin filaments that disassemble concomitantly with the MT severing.

We next investigated whether Cofilin-1 regulates the assembly/disassembly of branched F-actin at the secondary ingression. Upon Cofilin-1 depletion, the endogenous Arp2/3 subunit ARPC2 was detected at the secondary ingression in a greater proportion of ICBs
<figure><img src="image_10.png" /><figcaption>b</figcaption></figure>

<figure><img src="image_11.png" /></figure>

<figure><img src="image_12.png" /><figcaption>c</figcaption></figure>

<figure><img src="image_13.png" /></figure>

<figure><img src="image_14.png" /><figcaption>d</figcaption></figure>

<figure><img src="image_15.png" /><figcaption>e</figcaption></figure>

<figure><img src="image_16.png" /></figure>

<figure><img src="image_17.png" /><figcaption>f</figcaption></figure>

<figure><img src="image_18.png" /></figure>

<figure><img src="image_19.png" /></figure>

the secondary ingression and its disappearance at the time of the MT cut were confirmed in mouse 3T3 cells (Supplementary Fig. 3d). Of note, Arp2/3 can nucleate linear actin filaments upon activation by SPIN90⁵⁵. However, we did not detect SPIN90 together with Arp2/3 or F-actin at the secondary ingression (Supplementary Fig. 3e). We conclude that the F-actin that transiently accumulates with Cofilin-1 at the

secondary ingression (Fig. 1d) likely corresponds to branched actin filaments that disassemble concomitantly with the MT severing.

We next investigated whether Cofilin-1 regulates the assembly/disassembly of branched F-actin at the secondary ingression. Upon Cofilin-1 depletion, the endogenous Arp2/3 subunit ARPC2 was detected at the secondary ingression in a greater proportion of ICBs
**Fig. 2 | Cofilin-1 contributes to abscission by regulating F-actin depolymerization.** a Lysates of HeLa cells treated with either Control or Cofilin-1 siRNAs were blotted for endogenous Cofilin-1 and GAPDH (loading control). This experiment was repeated at least three times independently with similar results. b Left: Cumulative distribution of the fraction of cells that completed abscission (membrane cut measured by phase-contrast) as function of time after complete furrow ingression in cells treated with either Control or Cofilin-1 siRNAs (n ≥ 245 cells per condition from 4 independent experiments). Abscission times (from complete furrow ingression to abscission) were determined using phase contrast time-lapse microscopy. Right: Mean abscission time (min) ± SD in indicated cells, n ≥ 59 cells per condition, N = 4 independent experiments. Two-tailed unpaired Student's t-test. c Left: same analysis as in (b) for cells treated with either Control or Cofilin-1 siRNAs and transiently transfected with indicated constructs (n ≥ 183 cells per condition from 3 independent experiments). Right: Mean abscission times (min) ± SD in indicated cells, n ≥ 60 cells per condition, N = 3 independent experiments. One-way ANOVA with Tukey's multiple comparisons test. p-values after comparison to siControl + GFP alone are indicated. n.s. = non-significant (*p* > 0.05). d Top: Schemes illustrating how the removal of TMP induces the sequestration of

Cofilin-1-GFP at the surface of the mitochondria upon activation of anti-GFP nanobodies. Adapted from ref. 49. Bottom: Snapshots of a spinning disk confocal microscopy movie of cells stably co-expressing Cofilin-1-GFP and the Tom20-anti-GFP nanobody-SNAP-DHFR fusion protein (labelled with SiR-SNAP) either when TMP is present or 5 and 120 min upon TMP removal, as indicated. Scale bars = 20 µm. e Left: same analysis as in (b) for cells stably co-expressing Cofilin-1-GFP and the Tom20-anti-GFP nanobody-SNAP-DHFR fusion protein, treated with either Control or Cofilin-1 siRNAs, upon removal (-) of TMP or not (+) after furrow ingression (n ≥ 164 cells per condition from 3 independent experiments). Right: Mean abscission time (min) ± SD in indicated cells, n ≥ 38 cells per condition, N = 3 independent experiments. One-way ANOVA with Tukey's multiple comparisons test. f Left: same analysis as in (b) for cells treated with either Control or Cofilin-1 siRNAs and incubated with either DMSO or 7.5 nM Cytochalasin D (CytoD) (n ≥ 173 cells per condition from N = 3 independent experiments). Right: Mean abscission time (min) ± SD in indicated cells, n ≥ 51 cells per condition, N = 3 independent experiments. One-way ANOVA with Tukey's multiple comparisons test. n.s. = non-significant (*p* > 0.05).

(Supplementary Fig. 3f), suggesting that ARPC2 remained longer at this location in the absence of Cofilin-1. Consistent with this hypothesis, live cell imaging in cells stably expressing GFP-ARPC4 showed an increase in the mean residence time of ARPC4 at the secondary ingression before the MT cut in Cofilin-1-depleted cells (Fig. 3d). Similar increase was observed in non-depleted cells treated with the F-actin stabilizing drug Jasplakinolide (Jasp) (Supplementary Fig. 3g), indicating that actin dynamics is important for Arp2/3 removal at the secondary ingression. Of note, Cofilin-1 depletion did not impact global F-actin levels in the ICB (Supplementary Fig. 3h), nor F-actin levels (Supplementary Fig. 3i) or Arp2/3 levels at the secondary ingression (Supplementary Fig. 3j).

Together, these results indicate the existence of a local pool of branched F-actin at the secondary ingression shortly before the MT cut and show that Cofilin-1 controls the disassembly of branched F-actin at this location.

## Cofilin-1 promotes abscission by favoring MT severing through ESCRT-III-mediated recruitment of spasin but does not impact the membrane cut occurring later

Since Cofilin-1, Arp2/3 and F-actin all appear transiently at the secondary ingression and Cofilin-1 depletion perturbs Arp2/3 dynamics before the MT cut, we hypothesized that Cofilin-1 may influence abscission by regulating MT severing. When we monitored the MT cut using fluorescent SiR-Tubulin and the membrane cut (actual abscission) using phase contrast microscopy in the same cells throughout cytokinesis, we noticed that these are two clearly separate events (Fig. 4a and Supplementary movie 3). MT severing at the secondary ingression and abscission are generally thought to occur simultaneously –or almost simultaneously– in cultured cells (see discussion). In contrast, we found that the MT cut happened on average 90 min after furrow ingression, whereas the membrane cut occurred on average 185 min later, with a broader time distribution in control cells (Fig. 4b siControl). Of note, for each individual cell, the MT cut always preceded the membrane cut but there was no correlation between the timing of these two events, suggesting that they are not directly coupled (Supplementary Fig. 4a). Silencing Cofilin-1 strongly delayed the MT cut compared to control cells (Fig. 4b, left panel solid curves and middle panel). A similar delay was observed upon chemical stabilization of actin filaments in non-depleted cells treated with Jasp (Supplementary Fig. 4b). Importantly, when we measured, for each cell, the time elapsed between the MT cut and the membrane cut, we did not observe any differences between the control- and Cofilin-1-depleted cells (Fig. 4b, right panel). These results indicate that the delay in abscission observed upon Cofilin-1 depletion is fully explained by a delay in cutting the MTs and suggest that Cofilin-1 does not play a role once the MTs are cut.

To demonstrate whether Cofilin-1 promotes abscission by controlling the MT cut, we used the drug Batabulin which was shown to efficiently depolymerize the stable MTs present in the ICB, except in the very central part of the midbody¹³ (Fig. 4c). As previously reported¹³, the addition of Batabulin after complete furrow ingression in control cells was compatible with cell progression up to final abscission (determined by phase contrast) with no delay compared to DMSO-treated cells (Fig. 4d). Importantly, the abscission delay observed upon Cofilin-1 depletion was fully rescued when MTs were depolymerized using Batabulin (Fig. 4d). We conclude that Cofilin-1 promotes abscission by favoring MT severing but is not involved in the subsequent steps leading to abscission.

We next investigated how Cofilin-1 influences the MT cut required for abscission. First, we observed that the transient Cofilin-1 pool present at the secondary ingression precisely localized at the tip of the ESCRT-III cone labeled by the CHMP4B subunit in fixed control cells (Fig. 5a). Since the tip of the cone corresponds to the place where spasin will sever the MTs, we then analyzed whether Cofilin-1 depletion might perturb ESCRT-III and spasin behavior. The kinetics of appearance of the CHMP4B cone was not altered upon Cofilin-1 depletion (Fig. 5b, Time T1) but it took significantly more time for the cones to eventually trigger the MT cut (Fig. 5b, Time T2). This was not due to cone instability or retraction, since i) the MT cut occurred at a normal distance from the midbody (Fig. 5c), ii) the CHMP4B cones grew regularly –albeit with a slower rate– (Fig. 5d). Similar reduction in the growth rate of CHMP4B cone was observed in non-depleted cells treated with Jasp (Supplementary Fig. 4c). Of note, we observed that the mean intensity of CHMPIB—the ESCRT-III component that recruits spasin during cytokinesis—was decreased in late ICBs with secondary ingression in Cofilin-1-depleted cells compared to control cell, but unchanged in earlier ICBs without secondary ingression (Fig. 5e). As a consequence, the downstream recruitment of spasin was reduced in late ICBs with secondary ingression but was unaffected in earlier ICBs (Fig. 5f). Consistent with Cofilin-1 functioning upstream to spasin, the depletion of spasin did not impact on Cofilin-1 recruitment at the tip of the ESCRT-III cone (Supplementary Fig. 4d). We thus conclude that Cofilin-1 regulates the rate of ESCRT-III cone elongation and promotes abscission by controlling local MT severing through CHMPIB-dependent spasin recruitment at the secondary ingression.

## Branched F-actin promotes abscission by preventing excessive ESCRT-III cone elongation and favoring MT severing

We next wondered whether the presence of the branched F-actin pool at the secondary ingression was required for abscission. In normal fixed dividing cells, the Arp2/3 subunit ARPC2 localized precisely at the tip of the ESCRT-III cone labeled by its subunit IST1 (Fig. 6a). As
**Fig. 2 | Cofilin-1 contributes to abscission by regulating F-actin depolymerization.** a Lysates of HeLa cells treated with either Control or Cofilin-1 siRNAs were blotted for endogenous Cofilin-1 and GAPDH (loading control). This experiment was repeated at least three times independently with similar results. b Left: Cumulative distribution of the fraction of cells that completed abscission (membrane cut measured by phase-contrast) as function of time after complete furrow ingression in cells treated with either Control or Cofilin-1 siRNAs (n ≥ 245 cells per condition from 4 independent experiments). Abscission times (from complete furrow ingression to abscission) were determined using phase contrast time-lapse microscopy. Right: Mean abscission time (min) ± SD in indicated cells, n ≥ 59 cells per condition, N = 4 independent experiments. Two-tailed unpaired Student's t-test. c Left: same analysis as in (b) for cells treated with either Control or Cofilin-1 siRNAs and transiently transfected with indicated constructs (n ≥ 183 cells per condition from 3 independent experiments). Right: Mean abscission times (min) ± SD in indicated cells, n ≥ 60 cells per condition, N = 3 independent experiments. One-way ANOVA with Tukey's multiple comparisons test. *p*-values after comparison to siControl + GFP alone are indicated. n.s. = non-significant (*p* > 0.05). d Top: Schemes illustrating how the removal of TMP induces the sequestration of

Cofilin-1-GFP at the surface of the mitochondria upon activation of anti-GFP nanobodies. Adapted from ref. 49. Bottom: Snapshots of a spinning disk confocal microscopy movie of cells stably co-expressing Cofilin-1-GFP and the Tom20-anti-GFP nanobody-SNAP-DHFR fusion protein (labelled with SiR-SNAP) either when TMP is present or 5 and 120 min upon TMP removal, as indicated. Scale bars = 20 µm. e Left: same analysis as in (b) for cells stably co-expressing Cofilin-1-GFP and the Tom20-anti-GFP nanobody-SNAP-DHFR fusion protein, treated with either Control or Cofilin-1 siRNAs, upon removal (-) of TMP or not (+) after furrow ingression (n ≥ 164 cells per condition from 3 independent experiments). Right: Mean abscission time (min) ± SD in indicated cells, n ≥ 38 cells per condition, N = 3 independent experiments. One-way ANOVA with Tukey's multiple comparisons test. f Left: same analysis as in (b) for cells treated with either Control or Cofilin-1 siRNAs and incubated with either DMSO or 7.5 nM Cytochalasin D (CytoD) (n ≥ 173 cells per condition from N = 3 independent experiments). Right: Mean abscission time (min) ± SD in indicated cells, n ≥ 51 cells per condition, N = 3 independent experiments. One-way ANOVA with Tukey's multiple comparisons test. n.s. = non-significant (*p* > 0.05).

(Supplementary Fig. 3f), suggesting that ARPC2 remained longer at this location in the absence of Cofilin-1. Consistent with this hypothesis, live cell imaging in cells stably expressing GFP-ARPC4 showed an increase in the mean residence time of ARPC4 at the secondary ingression before the MT cut in Cofilin-1-depleted cells (Fig. 3d). Similar increase was observed in non-depleted cells treated with the F-actin stabilizing drug Jasplakinolide (Jasp) (Supplementary Fig. 3g), indicating that actin dynamics is important for Arp2/3 removal at the secondary ingression. Of note, Cofilin-1 depletion did not impact global F-actin levels in the ICB (Supplementary Fig. 3h), nor F-actin levels (Supplementary Fig. 3i) or Arp2/3 levels at the secondary ingression (Supplementary Fig. 3j).

Together, these results indicate the existence of a local pool of branched F-actin at the secondary ingression shortly before the MT cut and show that Cofilin-1 controls the disassembly of branched F-actin at this location.

## Cofilin-1 promotes abscission by favoring MT severing through ESCRT-III-mediated recruitment of spasin but does not impact the membrane cut occurring later

Since Cofilin-1, Arp2/3 and F-actin all appear transiently at the secondary ingression and Cofilin-1 depletion perturbs Arp2/3 dynamics before the MT cut, we hypothesized that Cofilin-1 may influence abscission by regulating MT severing. When we monitored the MT cut using fluorescent SiR-Tubulin and the membrane cut (actual abscission) using phase contrast microscopy in the same cells throughout cytokinesis, we noticed that these are two clearly separate events (Fig. 4a and Supplementary movie 3). MT severing at the secondary ingression and abscission are generally thought to occur simultaneously –or almost simultaneously– in cultured cells (see discussion). In contrast, we found that the MT cut happened on average 90 min after furrow ingression, whereas the membrane cut occurred on average 185 min later, with a broader time distribution in control cells (Fig. 4b siControl). Of note, for each individual cell, the MT cut always preceded the membrane cut but there was no correlation between the timing of these two events, suggesting that they are not directly coupled (Supplementary Fig. 4a). Silencing Cofilin-1 strongly delayed the MT cut compared to control cells (Fig. 4b, left panel solid curves and middle panel). A similar delay was observed upon chemical stabilization of actin filaments in non-depleted cells treated with Jasp (Supplementary Fig. 4b). Importantly, when we measured, for each cell, the time elapsed between the MT cut and the membrane cut, we did not observe any differences between the control- and Cofilin-1-depleted cells (Fig. 4b, right panel). These results indicate that the delay in abscission observed upon Cofilin-1 depletion is fully explained by a delay in cutting the MTs and suggest that Cofilin-1 does not play a role once the MTs are cut.

To demonstrate whether Cofilin-1 promotes abscission by controlling the MT cut, we used the drug Batabulin which was shown to efficiently depolymerize the stable MTs present in the ICB, except in the very central part of the midbody¹³ (Fig. 4c). As previously reported¹³, the addition of Batabulin after complete furrow ingression in control cells was compatible with cell progression up to final abscission (determined by phase contrast) with no delay compared to DMSO-treated cells (Fig. 4d). Importantly, the abscission delay observed upon Cofilin-1 depletion was fully rescued when MTs were depolymerized using Batabulin (Fig. 4d). We conclude that Cofilin-1 promotes abscission by favoring MT severing but is not involved in the subsequent steps leading to abscission.

We next investigated how Cofilin-1 influences the MT cut required for abscission. First, we observed that the transient Cofilin-1 pool present at the secondary ingression precisely localized at the tip of the ESCRT-III cone labeled by the CHMP4B subunit in fixed control cells (Fig. 5a). Since the tip of the cone corresponds to the place where spasin will sever the MTs, we then analyzed whether Cofilin-1 depletion might perturb ESCRT-III and spasin behavior. The kinetics of appearance of the CHMP4B cone was not altered upon Cofilin-1 depletion (Fig. 5b, Time T1) but it took significantly more time for the cones to eventually trigger the MT cut (Fig. 5b, Time T2). This was not due to cone instability or retraction, since i) the MT cut occurred at a normal distance from the midbody (Fig. 5c), ii) the CHMP4B cones grew regularly –albeit with a slower rate– (Fig. 5d). Similar reduction in the growth rate of CHMP4B cone was observed in non-depleted cells treated with Jasp (Supplementary Fig. 4c). Of note, we observed that the mean intensity of CHMPIB—the ESCRT-III component that recruits spasin during cytokinesis—was decreased in late ICBs with secondary ingression in Cofilin-1-depleted cells compared to control cell, but unchanged in earlier ICBs without secondary ingression (Fig. 5e). As a consequence, the downstream recruitment of spasin was reduced in late ICBs with secondary ingression but was unaffected in earlier ICBs (Fig. 5f). Consistent with Cofilin-1 functioning upstream to spasin, the depletion of spasin did not impact on Cofilin-1 recruitment at the tip of the ESCRT-III cone (Supplementary Fig. 4d). We thus conclude that Cofilin-1 regulates the rate of ESCRT-III cone elongation and promotes abscission by controlling local MT severing through CHMPIB-dependent spasin recruitment at the secondary ingression.

## Branched F-actin promotes abscission by preventing excessive ESCRT-III cone elongation and favoring MT severing

We next wondered whether the presence of the branched F-actin pool at the secondary ingression was required for abscission. In normal fixed dividing cells, the Arp2/3 subunit ARPC2 localized precisely at the tip of the ESCRT-III cone labeled by its subunit IST1 (Fig. 6a). As
<figure><img src="image_20.png" /></figure>

<figure><img src="image_21.png" /></figure>

<figure><img src="image_22.png" /></figure>

<figure><img src="image_23.png" /><figcaption>**Fig. 3** | Cofilin-1 colocalizes with a pool of branched F-actin at the secondary ingression before the MT cut and regulates the lifetime of this pool. **a** Staining of endogenous ARPC2, Tubulin and F-actin (labelled by fluorescent phalloidin). Scale bar = 10 µm. Arrowheads: ARPC2 and F-actin co-localization at the secondary ingression. This experiment was repeated at least three times independently with similar results. **b** Snapshots of a spinning disk confocal microscopy movie of cells stably co-expressing Cofilin-1-GFP and mApple-ARPC4 and incubated with fluorescent SiR-Tubulin. Arrowheads: Cofilin-1 and ARPC4 co-localization at the secondary ingression. Scale bar = 5 µm. **c** Intensity profile of Cofilin-1-GFP (green) and mApple-ARPC4 (magenta) at the secondary ingression as a function of time in cells described in **(b)**. Intensity values (arbitrary units) were normalized to the maximum</figcaption></figure>

<figure><img src="image_24.png" /></figure>

<figure><img src="image_25.png" /></figure>

intensity observed for each cell analyzed. Mean ± SD, *n* = 12 cells. All movies were registered with respect to the time of the MT cut (t0, red arrow). **d** Top left and bottom: Snapshots of a spinning disk confocal microscopy movie of cells stably expressing GFP-ARPC4 and incubated with fluorescent SiR-Tubulin after treatment with Control (top) or Cofilin-1 (bottom) siRNAs. Arrowheads: ARPC4 localization at the secondary ingression. Scale bar = 5 µm. Top right: The time elapsed between ARPC4 appearance at the secondary ingression and the MT cut was measured in the aforementioned conditions. Mean ± SD in indicated cells, *n* = 32 (siControl) or 18 (siCofilin-1) cells per condition from *N* = 4 independent experiments. Two-sided Mann-Whitney test.
<figure><img src="image_20.png" /></figure>

<figure><img src="image_21.png" /></figure>

<figure><img src="image_22.png" /></figure>

<figure><img src="image_23.png" /></figure>

<figure><img src="image_24.png" /></figure>

<figure><img src="image_25.png" /></figure>

**Fig. 3** | Cofilin-1 colocalizes with a pool of branched F-actin at the secondary ingression before the MT cut and regulates the lifetime of this pool. **a** Staining of endogenous ARPC2, Tubulin and F-actin (labelled by fluorescent phalloidin). Scale bar = 10 µm. Arrowheads: ARPC2 and F-actin co-localization at the secondary ingression. This experiment was repeated at least three times independently with similar results. **b** Snapshots of a spinning disk confocal microscopy movie of cells stably co-expressing Cofilin-1-GFP and mApple-ARPC4 and incubated with fluorescent SiR-Tubulin. Arrowheads: Cofilin-1 and ARPC4 co-localization at the secondary ingression. Scale bar = 5 µm. **c** Intensity profile of Cofilin-1-GFP (green) and mApple-ARPC4 (magenta) at the secondary ingression as a function of time in cells described in **(b)**. Intensity values (arbitrary units) were normalized to the maximum

intensity observed for each cell analyzed. Mean ± SD, *n* = 12 cells. All movies were registered with respect to the time of the MT cut (t0, red arrow). **d** Top left and bottom: Snapshots of a spinning disk confocal microscopy movie of cells stably expressing GFP-ARPC4 and incubated with fluorescent SiR-Tubulin after treatment with Control (top) or Cofilin-1 (bottom) siRNAs. Arrowheads: ARPC4 localization at the secondary ingression. Scale bar = 5 µm. Top right: The time elapsed between ARPC4 appearance at the secondary ingression and the MT cut was measured in the aforementioned conditions. Mean ± SD in indicated cells, *n* = 32 (siControl) or 18 (siCofilin-1) cells per condition from *N* = 4 independent experiments. Two-sided Mann-Whitney test.
<figure><img src="image_26.png" /></figure>

<figure><img src="image_27.png" /></figure>

<figure><img src="image_28.png" /></figure>

<figure><img src="image_29.png" /></figure>

expected, ARPC4 and F-actin transiently accumulated at the tip of the ESCRT-III cone a few minutes before the MT cut (Fig. 6b and Supplementary Fig. 5a, arrowheads). Functionally, preventing the formation of branched F-actin by adding the Arp2/3 inhibitor CK666 after furrow ingression resulted in delayed abscission compared to DMSO-treated cells (Fig. 6c). Furthermore, Arp2/3 inhibition delayed the MT cut after

ESCRT-III cone formation but left unchanged the time elapsed between the MT cut and the membrane cut (Fig. 6d and Supplementary Fig. 5b), indicating that once the MTs are cut, abscission occurs normally after Arp2/3 inhibition. Similar results were obtained in cells treated with high doses of either CytoD or LatA (Supplementary Fig. 5c, d). Importantly, the abscission delay due to Arp2/3 inhibition could be
<figure><img src="image_26.png" /></figure>

<figure><img src="image_27.png" /></figure>

<figure><img src="image_28.png" /></figure>

<figure><img src="image_29.png" /></figure>

expected, ARPC4 and F-actin transiently accumulated at the tip of the ESCRT-III cone a few minutes before the MT cut (Fig. 6b and Supplementary Fig. 5a, arrowheads). Functionally, preventing the formation of branched F-actin by adding the Arp2/3 inhibitor CK666 after furrow ingression resulted in delayed abscission compared to DMSO-treated cells (Fig. 6c). Furthermore, Arp2/3 inhibition delayed the MT cut after

ESCRT-III cone formation but left unchanged the time elapsed between the MT cut and the membrane cut (Fig. 6d and Supplementary Fig. 5b), indicating that once the MTs are cut, abscission occurs normally after Arp2/3 inhibition. Similar results were obtained in cells treated with high doses of either CytoD or LatA (Supplementary Fig. 5c, d). Importantly, the abscission delay due to Arp2/3 inhibition could be
**Fig. 4 | Cofilin-1 promotes abscission by favoring MT severing but does not influence the membrane cut occurring later.** a Snapshots of a widefield microscopy movie of HeLa cells incubated with fluorescent SiR-Tubulin and recorded both in phase contrast and in fluorescence. Time 0 corresponds to the time of complete furrow ingression. Red arrowhead: Microtubule cut (*t* = 70 min). Yellow brackets indicate the plasma membrane of the un-severed ICB. Yellow arrowhead: Membrane cut = physical abscission (*t* = 170 min). Yellow double-headed arrows: orientation of the midbody visualized by SiR-Tubulin. Note the rotation of the midbody at the time of the membrane cut. Scale bar = 10 µm. **b** Left: Cumulative distribution of the fraction of cells that completed MT cut (based on the SiR-tubulin channel, solid curves) and abscission (based on the phase contrast channel, dashed curves) as function of time after complete furrow ingression, in cells treated with either Control or Cofilin-1 siRNAs (*n* ≥ 190 cells per condition from 3 independent experiments). MT cut and abscission timings were determined in the same cells using the fluorescent SiR-Tubulin channel and the phase contrast time-lapse channel, respectively. Middle: Mean MT cut and abscission time (min) ± SD in indicated cells, *n* ≥ 61 cells per condition, *N* = 3 independent experiments. Two-tailed unpaired Student's t-test. **a** and **b** represent the time difference between the

abscission and the MT cut in Control and Cofilin-1-depleted cells, respectively. Right: **a** and **b** values defined in the middle panel have been represented. Mean **a** and **b** time difference (min) ± SD in indicated cells, *n* ≥ 61 cells per condition, *N* = 3 independent experiments. Two-tailed unpaired Student's t-test. **n.s.** = non-significant (*p* > 0.05). **c** Snapshots of a widefield microscopy movie of HeLa cells incubated with fluorescent SiR-Tubulin and recorded both in phase contrast and in fluorescence, after addition of either DMSO (left) or 2 µM Batabulin (right) after furrow ingression (between *t* = 0 and *t* = 10 min). Yellow stars: SiR-Tubulin labelling in the cell bodies after treatment. Note the complete disappearance of MTs (except in the central part of the midbody) upon Batabulin treatment. Scale bars = 10 µm. **d** Left: Cumulative distribution of the fraction of cells that completed abscission (based on the phase contrast channel) as function of time after complete furrow ingression, in cells treated with either Control or Cofilin-1 siRNAs and incubated or not with Batabulin after complete furrow ingression, as indicated (*n* ≥ 73 cells per condition from 3 independent experiments). Right: Mean abscission time (min) ± SD in indicated cells, *n* ≥ 16 cells per condition, *N* = 3 independent experiments. One-way ANOVA with Tukey's multiple comparisons test. **n.s.** = non-significant (*p* > 0.05).

fully rescued by depolymerizing the MTs with Batabulin (Fig. 6e), showing that branched F-actin specifically favors the MT cut during abscission.

To get further mechanistic insights, we next investigated whether Arp2/3 inhibition changed the behavior of spasin at the secondary ingression. We recorded spasin dynamics during cytokinesis by taking advantage of an inducible cell line that expressed low levels of GFP-spasin<sup>56</sup>. In control cells, spasin first accumulated at the midbody, then localized as a cone on one side of the midbody—consistent with spasin being recruited by CHMPIB there— and eventually concentrated at the tip of the cone before the MT cut (Fig. 7a and Supplementary movie 4). Arp2/3 inhibition led to a delay between the arrival of spasin at the cone and the MT cut (Fig. 7a and Supplementary movie 4), in agreement with the observed delay in the MT cut (Fig. 6d) and with a greater proportion of ICBs with endogenous spasin detected at the secondary ingression upon Arp2/3 inhibition (Supplementary Fig. 6a). Consistent with Arp2/3 acting upstream to spasin, the depletion of spasin did not prevent ARP2 recruitment at the tip of the ESCRT-III cone (Supplementary Fig. 6b). Furthermore, the mean intensity of endogenous spasin (as well as CHMPIB) at the secondary ingression was not modified but spasin localization appeared more elongated (Fig. 7b, top and bottom left panels and Supplementary Fig. 6c). We also noticed that spasin abnormally accumulated at the constriction site far away from the midbody in CK666-treated cells as compared to DMSO-treated cells (Fig. 7b, top and bottom right panels). Altogether, we conclude that the delay in the MT cut observed upon Arp2/3 inhibition is associated with an abnormal spasin distribution (shape and distance from the midbody) at the secondary ingression.

Since spasin is recruited by CHMPIB and concentrates at the tip of the ESCRT-III cone, these results led us to hypothesize that Arp2/3 may control the behavior of ESCRTs at the secondary ingression. Consistently, abnormally long CHMPIB-positive cones were observed upon Arp2/3 inhibition (Fig. 7c). These long CHMPIB-positive cones were also observed upon actin depolymerization using high doses of either CytoD or LatA (Supplementary Fig. 6d, e), arguing that branched F-actin normally sets the dimension of the ESCRT-III cone that polymerize from the midbody to the secondary ingression. To further investigate the role of Arp2/3 in restraining the extension of the ESCRT-III cone, we simultaneously recorded in live cells Arp2/3 (with mApple-ARP4C), ESCRT-III (with CHMP4B-GFP) and MTs (with SiR-Tubulin) as a function of time upon CK666 addition. In randomly picked control (DMSO-treated) cytokinetic cells that displayed a pool of Arp2/3 at the tip of the ESCRT-III cone at the beginning of the movie (time 0), we observed a limited growth of the cone before MTs were severed (Supplementary movie 5, Fig. 7d and Fig. 7e-i each black curve

corresponds to an individual cell). MT severing occurred within approximately 15 min (Fig. 7e-ii), at a distance of approximately 2 µm from the midbody (Fig. 7e-iii). In contrast, in cells treated with CK666, we observed 1) a disappearance of the Arp2/3 pool at the tip of the cone and 2) an abnormal growth of the ESCRT-III cone due to ESCRT-III polymerization for an extended period of time before MT were eventually severed (Supplementary movie 5, Fig. 7f and Fig. 7e-i green curves). MT severing occurred typically 30-70 min after the addition of the drug (Fig. 7e-ii), at a distance of approximately 4 µm (Fig. 7e-iii). In addition, ESCRT-III cones detached more frequently from the midbody in CK666-treated cells (26.9%, *n* = 52) compared to DMSO-treated cells (9.8%, *n* = 41) (Chi² contingency test: *p* = 0.037). We propose that the Arp2/3-positive branched F-actin pool present at the tip of the ESCRT-III cone limits its extension, thereby preventing the sliding of spasin along the ICB and favors productive MT severing close to the midbody. This likely explains why in the absence of Arp2/3, MTs are not severed properly and thus abscission is delayed.

## Discussion

We reveal here a role of Arp2/3-dependent branched F-actin together with Cofilin-1 in promoting cytokinetic abscission through the specific regulation of MT severing at the secondary ingression.

To characterize the function of Cofilin-1 and Arp2/3 in abscission, we monitored the MT cut and the membrane cut in the same dividing cells and realized that these two events are far from being simultaneous or almost simultaneous, as generally assumed in cultured cells. Reported measurements of abscission timing give various mean values depending on the technique that is used, even for a single cell type such as HeLa cells: (1) time-lapse imaging of fluorescently labelled tubulin<sup>18,27,32,57–62</sup>; (2) measurement of cytoplasmic exchange of photoactivable proteins between the two daughter cells, which ceases after abscission or at least when the ICB diameter is small enough<sup>13,63</sup>; or (3) time-lapse visualization of the physical cut of the ICB (membrane cut) using phase contrast microscopy<sup>19,28–30,64,65</sup>. The observation that the MT cut and the membrane cut are two separated events likely explains the discrepancy in the timing of abscission between studies reported in the literature.

Whether F-actin has a function in the final steps of cytokinesis, after furrow ingression, is a long-standing question. The fact that F-actin must be globally disassembled within the ICB to promote abscission is well established<sup>19,28,29,32,33</sup>. In contrast, an active role of F-actin in abscission, likely locally and/or transiently, is still debated. In a seminal study describing the constricting role of ESCRT-III at the secondary ingression, the addition of the F-actin polymerization inhibitor Latrunculin B (LatB) after furrow ingression did not alter the timing of abscission<sup>13</sup>. In contrast, adding the F-actin polymerization
**Fig. 4 | Cofilin-1 promotes abscission by favoring MT severing but does not influence the membrane cut occurring later.** a Snapshots of a widefield microscopy movie of HeLa cells incubated with fluorescent SiR-Tubulin and recorded both in phase contrast and in fluorescence. Time 0 corresponds to the time of complete furrow ingression. Red arrowhead: Microtubule cut (t = 70 min). Yellow brackets indicate the plasma membrane of the un-severed ICB. Yellow arrowhead: Membrane cut = physical abscission (t = 170 min). Yellow double-headed arrows: orientation of the midbody visualized by SiR-Tubulin. Note the rotation of the midbody at the time of the membrane cut. Scale bar = 10 µm. **b** Left: Cumulative distribution of the fraction of cells that completed MT cut (based on the SiR-tubulin channel, solid curves) and abscission (based on the phase contrast channel, dashed curves) as function of time after complete furrow ingression, in cells treated with either Control or Cofilin-1 siRNAs (n ≥ 190 cells per condition from 3 independent experiments). MT cut and abscission timings were determined in the same cells using the fluorescent SiR-Tubulin channel and the phase contrast time-lapse channel, respectively. Middle: Mean MT cut and abscission time (min) ± SD in indicated cells, n ≥ 61 cells per condition, N = 3 independent experiments. Two-tailed unpaired Student's t-test. **a** and **b** represent the time difference between the

abscission and the MT cut in Control and Cofilin-1-depleted cells, respectively. Right: **a** and **b** values defined in the middle panel have been represented. Mean **a** and **b** time difference (min) ± SD in indicated cells, n ≥ 61 cells per condition, N = 3 independent experiments. Two-tailed unpaired Student's t-test. **n.s.** = non-significant (*p* > 0.05). **c** Snapshots of a widefield microscopy movie of HeLa cells incubated with fluorescent SiR-Tubulin and recorded both in phase contrast and in fluorescence, after addition of either DMSO (left) or 2 µM Batabulin (right) after furrow ingression (between t = 0 and t = 10 min). Yellow stars: SiR-Tubulin labelling in the cell bodies after treatment. Note the complete disappearance of MTs (except in the central part of the midbody) upon Batabulin treatment. Scale bars = 10 µm. **d** Left: Cumulative distribution of the fraction of cells that completed abscission (based on the phase contrast channel) as function of time after complete furrow ingression, in cells treated with either Control or Cofilin-1 siRNAs and incubated or not with Batabulin after complete furrow ingression, as indicated (n ≥ 73 cells per condition from 3 independent experiments). Right: Mean abscission time (min) ± SD in indicated cells, n ≥ 16 cells per condition, N = 3 independent experiments. One-way ANOVA with Tukey's multiple comparisons test. **n.s.** = non-significant (*p* > 0.05).

fully rescued by depolymerizing the MTs with Batabulin (Fig. 6e), showing that branched F-actin specifically favors the MT cut during abscission.

To get further mechanistic insights, we next investigated whether Arp2/3 inhibition changed the behavior of spasin at the secondary ingression. We recorded spasin dynamics during cytokinesis by taking advantage of an inducible cell line that expressed low levels of GFP-spasin¹⁰. In control cells, spasin first accumulated at the midbody, then localized as a cone on one side of the midbody—consistent with spasin being recruited by CHMPIB there— and eventually concentrated at the tip of the cone before the MT cut (Fig. 7a and Supplementary movie 4). Arp2/3 inhibition led to a delay between the arrival of spasin at the cone and the MT cut (Fig. 7a and Supplementary movie 4), in agreement with the observed delay in the MT cut (Fig. 6d) and with a greater proportion of ICBs with endogenous spasin detected at the secondary ingression upon Arp2/3 inhibition (Supplementary Fig. 6a). Consistent with Arp2/3 acting upstream to spasin, the depletion of spasin did not prevent ARP2 recruitment at the tip of the ESCRT-III cone (Supplementary Fig. 6b). Furthermore, the mean intensity of endogenous spasin (as well as CHMPIB) at the secondary ingression was not modified but spasin localization appeared more elongated (Fig. 7b, top and bottom left panels and Supplementary Fig. 6c). We also noticed that spasin abnormally accumulated at the constriction site far away from the midbody in CK666-treated cells as compared to DMSO-treated cells (Fig. 7b, top and bottom right panels). Altogether, we conclude that the delay in the MT cut observed upon Arp2/3 inhibition is associated with an abnormal spasin distribution (shape and distance from the midbody) at the secondary ingression.

Since spasin is recruited by CHMPIB and concentrates at the tip of the ESCRT-III cone, these results led us to hypothesize that Arp2/3 may control the behavior of ESCRTs at the secondary ingression. Consistently, abnormally long CHMPIB-positive cones were observed upon Arp2/3 inhibition (Fig. 7c). These long CHMPIB-positive cones were also observed upon actin depolymerization using high doses of either CytoD or LatA (Supplementary Fig. 6d, e), arguing that branched F-actin normally sets the dimension of the ESCRT-III cone that polymerize from the midbody to the secondary ingression. To further investigate the role of Arp2/3 in restraining the extension of the ESCRT-III cone, we simultaneously recorded in live cells Arp2/3 (with mApple-ARP4C), ESCRT-III (with CHMP4B-GFP) and MTs (with SiR-Tubulin) as a function of time upon CK666 addition. In randomly picked control (DMSO-treated) cytokinetic cells that displayed a pool of Arp2/3 at the tip of the ESCRT-III cone at the beginning of the movie (time 0), we observed a limited growth of the cone before MTs were severed (Supplementary movie 5, Fig. 7d and Fig. 7e-i each black curve

corresponds to an individual cell). MT severing occurred within approximately 15 min (Fig. 7e-ii), at a distance of approximately 2 µm from the midbody (Fig. 7e-iii). In contrast, in cells treated with CK666, we observed 1) a disappearance of the Arp2/3 pool at the tip of the cone and 2) an abnormal growth of the ESCRT-III cone due to ESCRT-III polymerization for an extended period of time before MT were eventually severed (Supplementary movie 5, Fig. 7f and Fig. 7e-i green curves). MT severing occurred typically 30-70 min after the addition of the drug (Fig. 7e-ii), at a distance of approximately 4 µm (Fig. 7e-iii). In addition, ESCRT-III cones detached more frequently from the midbody in CK666-treated cells (26.9%, n = 52) compared to DMSO-treated cells (9.8%, n = 41) (Chi² contingency test: *p* = 0.037). We propose that the Arp2/3-positive branched F-actin pool present at the tip of the ESCRT-III cone limits its extension, thereby preventing the sliding of spasin along the ICB and favors productive MT severing close to the midbody. This likely explains why in the absence of Arp2/3, MTs are not severed properly and thus abscission is delayed.

## Discussion

We reveal here a role of Arp2/3-dependent branched F-actin together with Cofilin-1 in promoting cytokinetic abscission through the specific regulation of MT severing at the secondary ingression.

To characterize the function of Cofilin-1 and Arp2/3 in abscission, we monitored the MT cut and the membrane cut in the same dividing cells and realized that these two events are far from being simultaneous or almost simultaneous, as generally assumed in cultured cells. Reported measurements of abscission timing give various mean values depending on the technique that is used, even for a single cell type such as HeLa cells: (1) time-lapse imaging of fluorescently labelled tubulin¹⁸,²⁷,³²,⁵⁷⁻⁶²; (2) measurement of cytoplasmic exchange of photoactivable proteins between the two daughter cells, which ceases after abscission or at least when the ICB diameter is small enough¹³,⁶³; or (3) time-lapse visualization of the physical cut of the ICB (membrane cut) using phase contrast microscopy¹⁹,²⁸⁻³⁰,⁶⁴,⁶⁵. The observation that the MT cut and the membrane cut are two separated events likely explains the discrepancy in the timing of abscission between studies reported in the literature.

Whether F-actin has a function in the final steps of cytokinesis, after furrow ingression, is a long-standing question. The fact that F-actin must be globally disassembled within the ICB to promote abscission is well established¹⁹,²⁸,²⁹,³²,³³. In contrast, an active role of F-actin in abscission, likely locally and/or transiently, is still debated. In a seminal study describing the constricting role of ESCRT-III at the secondary ingression, the addition of the F-actin polymerization inhibitor Latrunculin B (LatB) after furrow ingression did not alter the timing of abscission¹³. In contrast, adding the F-actin polymerization
<figure><img src="image_30.png" /><figcaption>b</figcaption></figure>

<figure><img src="image_31.png" /><figcaption>c</figcaption></figure>

<figure><img src="image_32.png" /><figcaption>d</figcaption></figure>

<figure><img src="image_33.png" /><figcaption>e</figcaption></figure>

<figure><img src="image_34.png" /><figcaption>f</figcaption></figure>

<figure><img src="image_35.png" /></figure>

inhibitor Cytochalasin D after furrow ingression increased binucleated cells formation due to bridge regression after midbody formation, indicating that F-actin is required for late ICB stability and/or completion of abscission³⁴. Furthermore, incubation with Blebbistatin after furrow ingression prevented the formation of the secondary ingression, indicating a role of myosin II and, presumably, F-actin in this

process⁶⁶. Failure to see a role of F-actin in late cytokinetic steps in some studies likely stems from differences in drugs or doses that have been used or exact time of addition after furrow ingression. In particular, LatB is less efficient than LatA and is likely inactivated by serum⁶⁷, which might explain why defects on abscission were not previously detected¹³. Here, we found similar effects of relatively high doses of
<figure><img src="image_30.png" /><figcaption>b</figcaption></figure>

<figure><img src="image_31.png" /><figcaption>c</figcaption></figure>

<figure><img src="image_32.png" /><figcaption>d</figcaption></figure>

<figure><img src="image_33.png" /><figcaption>e</figcaption></figure>

<figure><img src="image_34.png" /><figcaption>f</figcaption></figure>

<figure><img src="image_35.png" /></figure>

inhibitor Cytochalasin D after furrow ingression increased binucleated cells formation due to bridge regression after midbody formation, indicating that F-actin is required for late ICB stability and/or completion of abscission³⁴. Furthermore, incubation with Blebbistatin after furrow ingression prevented the formation of the secondary ingression, indicating a role of myosin II and, presumably, F-actin in this

process⁶⁶. Failure to see a role of F-actin in late cytokinetic steps in some studies likely stems from differences in drugs or doses that have been used or exact time of addition after furrow ingression. In particular, LatB is less efficient than LatA and is likely inactivated by serum⁶⁷, which might explain why defects on abscission were not previously detected¹³. Here, we found similar effects of relatively high doses of
**Fig. 5 | The MT severing delay observed in Cofilin-1-depleted cells is associated with a defective recruitment of the ESCRT-III subunit CHMP1B and spastin.**

a Top: Staining of endogenous Cofilin-1, CHMP4B and Tubulin in a late ICB with secondary ingression (arrowhead). Scale bar = 2 µm. Bottom: Intensity profile of CHMP4B (green) and Cofilin-1 (magenta) between * and ** along the ICB from the top merge picture. This experiment was repeated at least three times independently with similar results. b Top: Snapshots of a spinning disk confocal microscopy movie of cells stably expressing CHMP4B-GFP and incubated with fluorescent SIR-Tubulin. T1: time from CHMP4B-GFP recruitment at the midbody (t = 0 min) to appearance at the secondary ingression (arrowhead); T2: time from CHMP4B-GFP appearance at the secondary ingression to the MT cut. Scale bar = 5 µm. Bottom: Mean T1 and T2 (min) ± SD in indicated cells, n = 10–35 cells per condition, N = 4 independent experiments (violin plots). Two-tailed unpaired Student's t-test with Welch's correction. n.s. = non-significant (*p* > 0.05). c Quantification of CHMP4B-GFP cone size at the timepoint just before the cut of the MTs from the movies described in (d). Mean ± SD, n = 8–32 cells per condition, N = 3 independent experiments (violin plots). Two-tailed unpaired Student's t-test. n.s. = non-significant (*p* > 0.05). d Left: Snapshots of a spinning disk confocal microscopy

movie (8 min intervals) of cells stably expressing CHMP4B-GFP and incubated with fluorescent SIR-Tubulin and treated with either Control or Cofilin-1 siRNAs. Arrowhead: tip of the ESCRT-III cone. Scale bar = 2 µm. Right: Quantification of the growth rate of CHMP4B cone in indicated cells. Mean ± SD, n = 8–32 cells per condition, N = 3 independent experiments (violin plots). Two-tailed unpaired Student's t-test. e Top: Representative images of endogenous CHMP1B and Tubulin in cells treated with either Control or Cofilin-1 siRNAs. Arrowhead: secondary ingression. Scale bars = 5 µm. Bottom: mean fluorescence intensity of CHMP1B (arbitrary units) at the midbody (late ICBs without secondary ingression) or at the midbody + secondary ingression (late ICBs with secondary ingression) in indicated cells. Mean ± SD, n = 7–21 cells per condition, N = 3 independent experiments (violin plots). Intensities are normalized in each experiment to the mean intensity of siControl cells in late ICB without secondary ingression. One-way ANOVA with Tukey's multiple comparisons test. n.s. = non-significant (*p* > 0.05). f Same as in (e) for endogenous spastin. Mean ± SD in indicated cells, n = 8–20 cells per condition, N = 3 independent experiments. One-way ANOVA with Tukey's multiple comparisons test. n.s. = non-significant (*p* > 0.05).

CytoD and LatA on abscission, MT cut and ESCRT-III polymerization. Of note, continuous incubation of dividing cells with CK666 did not result in binucleated cells, suggesting that Arp2/3 is not required for furrow ingression nor for ICB stability, but whether it perturbed abscission had not been investigated³³. Here, we used time-lapse phase contrast microscopy to visualize the actual physical cut of the ICB and treated the cells with CK666 after furrow ingression. This approach demonstrated that branched F-actin promotes abscission.

Based on our localization data and functional analysis, we further involved two actin partners, the Arp2/3 complex and the actin disassembling protein Cofilin-1, in cytokinetic abscission. Using live cell imaging, we discovered a previously overlooked, transient pool of Cofilin-1 and Arp2/3, which appear together at the secondary ingression 15–20 min before severing of the MTs. Furthermore, the disappearance of Cofilin-1 and Arp2/3 at the secondary ingression occurs simultaneously with the MT cut—according to our time-resolution of 5 min—suggesting that these two events are tightly coupled. A spike of F-actin at the secondary ingression in late cytokinetic steps has been previously reported³⁴,⁶⁶. However, the nature of this actin pool, its relationship with MT disassembly and its precise role in abscission remained unknown. We speculate that this pool likely corresponds to the Arp2/3-F-actin pool that we characterized here. Further work would be needed to investigate whether actin and tubulin crosslinkers known to localize at the secondary ingression, such as the protein Gas2l3⁶⁸,⁶⁹, might regulate the assembly of the branched actin pool at this location and thereby promote the MT cut. Importantly, this actin pool precisely assembles at the tip of ESCRT-III cones. Of note, two components of Arp2/3 (ARPC3 and ARPC5L) and Cofilin-1 have been recently identified by mass spectrometry upon coimmunoprecipitation with CHMP4B during cytokinesis⁷⁰. These interactions, either direct or indirect, might account for the observed overlap of Arp2/3 and Cofilin-1 with the ESCRT-III machinery at the secondary ingression.

How Arp2/3 and F-actin transiently accumulate at the secondary ingression? Our data argue that Arp2/3 is not activated by SPIN90 – which promotes Arp2/3-dependent linear F-actin⁵⁵– suggesting that Arp2/3 nucleates branched F-actin at the secondary ingression. Future investigations will nevertheless be required to determine how Arp2/3 is activated to assemble branched F-actin at this site. Since Cofilin-1 is continuously present with Arp2/3 and F-actin at the secondary ingression for 15–20 min before the MT cut, it is likely that a balance of Arp2/3 activators and Cofilin-1 regulates branched F-actin turnover at this location. Consistent with the known function of Cofilin-1 in controlling F-actin disassembly and dissociation of Arp2/3-mediated actin branches⁴⁷,⁷¹⁻⁷⁵, we found that Cofilin-1 depletion increases the residence time of Arp2/3 at the secondary ingression. This is in agreement with the discrete localization of Cofilin-1 at the secondary ingression.

Importantly, low doses of the F-actin depolymerization drugs Latrunculin-A or Cytochalasin D (which have no effect on abscission in control cells) rescue the abscission delay observed in Cofilin-1-depleted cells, indicating a function of Cofilin-1 in remodeling F-actin for proper abscission. Of note, Cofilin-1 does not increase F-actin levels all over the ICB. This contrasts with a global regulation of Arp2/3 and F-actin in the whole ICB by the oxidoreductase MICAL1²⁹,⁷⁶, which is known to synergize with Cofilin-1 to disassemble F-actin in vitro⁷⁷⁻⁷⁹. Thus, MICAL1 and Cofilin-1 appear to play distinct role during cytokinetic abscission. Of note, Arp2/3 acutely disappears from the secondary ingression concomitantly with the MT cut. This could be explained by an increase in Cofilin-1 activity or by the inactivation of Arp2/3 activators at the time of the MT severing.

Mechanistically, we propose that Arp2/3 together with Cofilin-1 controls the timing of abscission by favoring the severing of the MTs at the secondary ingression (Fig. 8). In Cofilin-1-depleted cells and in CK666-treated cells, the recruitment and the behavior of spastin is impaired, respectively. Upon Cofilin-1 depletion, the residence time of Arp2/3 is increased, and the growth rate of ESCRT-III cones is decreased. This is associated with a reduction of CHMP1B at the ICB, which likely explains the observed defective recruitment of spastin and the delay in the MT cut. Interestingly, stabilizing F-actin using Jasplakinolide reduces the growth rate of ESCRT-III cones, delays the MT cut and increases the residence time of Arp2/3, as observed upon Cofilin-1 depletion. Cofilin-1 depletion might thus reduce the dynamics of the branched F-actin pool at the tip of the ESCRT-III cone. We speculate that in Cofilin-1-depleted cells, the presence of a non-dynamic pool of F-actin at this location creates local resistance that slows down the elongation of the ESCRT-III cone and prevents normal CHMP1B incorporation. In contrast, removing Arp2/3 by adding CK666 does not impair spastin recruitment but profoundly alters its behavior, which also results in delaying MT severing. Using live and fixed cell imaging, we found that spastin is first recruited at the midbody, then accumulates at the tip of the ESCRT-III cone where it promotes local MT severing. This reveals spastin dynamics during cytokinesis. Either CK666, Cytochalasin D or Latrunculin A treatments have a strong effect on the geometry of the ESCRT-III cone, which grows continuously from the midbody over several micrometers for an extended period of time. As a consequence, spastin at the tip of the cone continuously progresses away from the midbody. We hypothesize that this does not give enough time for spastin to sufficiently depolymerize MT at a given location, which thus delays MT severing. Reinforcing the notion of an abnormal spastin-mediated severing in CK666-treated cells, we noticed that bridge MTs appear to fade over time upon CK666 treatment, suggesting continuous depolymerization, as previously observed in spastin-depleted cells²⁷. At the mesoscopic level, we
<caption>**Fig. 5** | The MT severing delay observed in Cofilin-1-depleted cells is associated with a defective recruitment of the ESCRT-III subunit CHMP1B and spastin.</caption>

a Top: Staining of endogenous Cofilin-1, CHMP4B and Tubulin in a late ICB with secondary ingression (arrowhead). Scale bar = 2 µm. Bottom: Intensity profile of CHMP4B (green) and Cofilin-1 (magenta) between * and ** along the ICB from the top merge picture. This experiment was repeated at least three times independently with similar results. b Top: Snapshots of a spinning disk confocal microscopy movie of cells stably expressing CHMP4B-GFP and incubated with fluorescent SIR-Tubulin. T1: time from CHMP4B-GFP recruitment at the midbody (t = 0 min) to appearance at the secondary ingression (arrowhead); T2: time from CHMP4B-GFP appearance at the secondary ingression to the MT cut. Scale bar = 5 µm. Bottom: Mean T1 and T2 (min) ± SD in indicated cells, n = 10–35 cells per condition, N = 4 independent experiments (violin plots). Two-tailed unpaired Student's t-test with Welch's correction. n.s. = non-significant (*p* > 0.05). c Quantification of CHMP4B-GFP cone size at the timepoint just before the cut of the MTs from the movies described in (d). Mean ± SD, n = 8–32 cells per condition, N = 3 independent experiments (violin plots). Two-tailed unpaired Student's t-test. n.s. = non-significant (*p* > 0.05). d Left: Snapshots of a spinning disk confocal microscopy

movie (8 min intervals) of cells stably expressing CHMP4B-GFP and incubated with fluorescent SIR-Tubulin and treated with either Control or Cofilin-1 siRNAs. Arrowhead: tip of the ESCRT-III cone. Scale bar = 2 µm. Right: Quantification of the growth rate of CHMP4B cone in indicated cells. Mean ± SD, n = 8–32 cells per condition, N = 3 independent experiments (violin plots). Two-tailed unpaired Student's t-test. e Top: Representative images of endogenous CHMP1B and Tubulin in cells treated with either Control or Cofilin-1 siRNAs. Arrowhead: secondary ingression. Scale bars = 5 µm. Bottom: mean fluorescence intensity of CHMP1B (arbitrary units) at the midbody (late ICBs without secondary ingression) or at the midbody + secondary ingression (late ICBs with secondary ingression) in indicated cells. Mean ± SD, n = 7–21 cells per condition, N = 3 independent experiments (violin plots). Intensities are normalized in each experiment to the mean intensity of siControl cells in late ICB without secondary ingression. One-way ANOVA with Tukey's multiple comparisons test. n.s. = non-significant (*p* > 0.05). f Same as in (e) for endogenous spastin. Mean ± SD in indicated cells, n = 8–20 cells per condition, N = 3 independent experiments. One-way ANOVA with Tukey's multiple comparisons test. n.s. = non-significant (*p* > 0.05).

CytoD and LatA on abscission, MT cut and ESCRT-III polymerization. Of note, continuous incubation of dividing cells with CK666 did not result in binucleated cells, suggesting that Arp2/3 is not required for furrow ingression nor for ICB stability, but whether it perturbed abscission had not been investigated³³. Here, we used time-lapse phase contrast microscopy to visualize the actual physical cut of the ICB and treated the cells with CK666 after furrow ingression. This approach demonstrated that branched F-actin promotes abscission.

Based on our localization data and functional analysis, we further involved two actin partners, the Arp2/3 complex and the actin disassembling protein Cofilin-1, in cytokinetic abscission. Using live cell imaging, we discovered a previously overlooked, transient pool of Cofilin-1 and Arp2/3, which appear together at the secondary ingression 15–20 min before severing of the MTs. Furthermore, the disappearance of Cofilin-1 and Arp2/3 at the secondary ingression occurs simultaneously with the MT cut — according to our time-resolution of 5 min — suggesting that these two events are tightly coupled. A spike of F-actin at the secondary ingression in late cytokinetic steps has been previously reported³⁴,⁶⁶. However, the nature of this actin pool, its relationship with MT disassembly and its precise role in abscission remained unknown. We speculate that this pool likely corresponds to the Arp2/3-F-actin pool that we characterized here. Further work would be needed to investigate whether actin and tubulin crosslinkers known to localize at the secondary ingression, such as the protein Gas2l3⁶⁸,⁶⁹, might regulate the assembly of the branched actin pool at this location and thereby promote the MT cut. Importantly, this actin pool precisely assembles at the tip of ESCRT-III cones. Of note, two components of Arp2/3 (ARPC3 and ARPC5L) and Cofilin-1 have been recently identified by mass spectrometry upon coimmunoprecipitation with CHMP4B during cytokinesis⁷⁰. These interactions, either direct or indirect, might account for the observed overlap of Arp2/3 and Cofilin-1 with the ESCRT-III machinery at the secondary ingression.

How Arp2/3 and F-actin transiently accumulate at the secondary ingression? Our data argue that Arp2/3 is not activated by SPIN90 — which promotes Arp2/3-dependent linear F-actin⁵⁵— suggesting that Arp2/3 nucleates branched F-actin at the secondary ingression. Future investigations will nevertheless be required to determine how Arp2/3 is activated to assemble branched F-actin at this site. Since Cofilin-1 is continuously present with Arp2/3 and F-actin at the secondary ingression for 15–20 min before the MT cut, it is likely that a balance of Arp2/3 activators and Cofilin-1 regulates branched F-actin turnover at this location. Consistent with the known function of Cofilin-1 in controlling F-actin disassembly and dissociation of Arp2/3-mediated actin branches⁴⁷,⁷¹⁻⁷⁵, we found that Cofilin-1 depletion increases the residence time of Arp2/3 at the secondary ingression. This is in agreement with the discrete localization of Cofilin-1 at the secondary ingression.

Importantly, low doses of the F-actin depolymerization drugs Latrunculin-A or Cytochalasin D (which have no effect on abscission in control cells) rescue the abscission delay observed in Cofilin-1-depleted cells, indicating a function of Cofilin-1 in remodeling F-actin for proper abscission. Of note, Cofilin-1 does not increase F-actin levels all over the ICB. This contrasts with a global regulation of Arp2/3 and F-actin in the whole ICB by the oxidoreductase MICAL1²⁹,⁷⁶, which is known to synergize with Cofilin-1 to disassemble F-actin in vitro⁷⁷⁻⁷⁹. Thus, MICAL1 and Cofilin-1 appear to play distinct role during cytokinetic abscission. Of note, Arp2/3 acutely disappears from the secondary ingression concomitantly with the MT cut. This could be explained by an increase in Cofilin-1 activity or by the inactivation of Arp2/3 activators at the time of the MT severing.

Mechanistically, we propose that Arp2/3 together with Cofilin-1 controls the timing of abscission by favoring the severing of the MTs at the secondary ingression (Fig. 8). In Cofilin-1-depleted cells and in CK666-treated cells, the recruitment and the behavior of spastin is impaired, respectively. Upon Cofilin-1 depletion, the residence time of Arp2/3 is increased, and the growth rate of ESCRT-III cones is decreased. This is associated with a reduction of CHMP1B at the ICB, which likely explains the observed defective recruitment of spastin and the delay in the MT cut. Interestingly, stabilizing F-actin using Jasplakinolide reduces the growth rate of ESCRT-III cones, delays the MT cut and increases the residence time of Arp2/3, as observed upon Cofilin-1 depletion. Cofilin-1 depletion might thus reduce the dynamics of the branched F-actin pool at the tip of the ESCRT-III cone. We speculate that in Cofilin-1-depleted cells, the presence of a non-dynamic pool of F-actin at this location creates local resistance that slows down the elongation of the ESCRT-III cone and prevents normal CHMP1B incorporation. In contrast, removing Arp2/3 by adding CK666 does not impair spastin recruitment but profoundly alters its behavior, which also results in delaying MT severing. Using live and fixed cell imaging, we found that spastin is first recruited at the midbody, then accumulates at the tip of the ESCRT-III cone where it promotes local MT severing. This reveals spastin dynamics during cytokinesis. Either CK666, Cytochalasin D or Latrunculin A treatments have a strong effect on the geometry of the ESCRT-III cone, which grows continuously from the midbody over several micrometers for an extended period of time. As a consequence, spastin at the tip of the cone continuously progresses away from the midbody. We hypothesize that this does not give enough time for spastin to sufficiently depolymerize MT at a given location, which thus delays MT severing. Reinforcing the notion of an abnormal spastin-mediated severing in CK666-treated cells, we noticed that bridge MTs appear to fade over time upon CK666 treatment, suggesting continuous depolymerization, as previously observed in spastin-depleted cells²⁷. At the mesoscopic level, we
<figure><img src="image_36.png" /><figcaption>b</figcaption></figure>

<figure><img src="image_37.png" /><figcaption>c</figcaption></figure>

<figure><img src="image_38.png" /><figcaption>d</figcaption></figure>

<figure><img src="image_39.png" /></figure>

<figure><img src="image_40.png" /><figcaption>e</figcaption></figure>

<figure><img src="image_41.png" /></figure>

speculate that the branched F-actin meshwork acts as a physical barrier that blocks the abnormal extension of the ESCRT-III polymers. To our knowledge, the Arp2/3 pool at the tip of the ESCRT-III cone is the first reported regulatory component that sets the dimensions of the ESCRT-III cone, which appears critical to control spastin activity. Altogether, these results highlight the local requirement of Cofilin-1

and Arp2/3-dependent branched F-actin in abscission by controlling the correct recruitment and stability of the spastin pool at the secondary ingression.

In summary, our results demonstrate a role of the actin cytoskeleton in the late steps of cytokinesis. Indeed, we found that branched F-actin and Cofilin-1 were specifically required for the MT cut. This
<figure><img src="image_36.png" /><figcaption>b</figcaption></figure>

<figure><img src="image_37.png" /><figcaption>c</figcaption></figure>

<figure><img src="image_38.png" /><figcaption>d</figcaption></figure>

<figure><img src="image_39.png" /></figure>

<figure><img src="image_40.png" /><figcaption>e</figcaption></figure>

<figure><img src="image_41.png" /></figure>

speculate that the branched F-actin meshwork acts as a physical barrier that blocks the abnormal extension of the ESCRT-III polymers. To our knowledge, the Arp2/3 pool at the tip of the ESCRT-III cone is the first reported regulatory component that sets the dimensions of the ESCRT-III cone, which appears critical to control spastin activity. Altogether, these results highlight the local requirement of Cofilin-1

and Arp2/3-dependent branched F-actin in abscission by controlling the correct recruitment and stability of the spastin pool at the secondary ingression.

In summary, our results demonstrate a role of the actin cytoskeleton in the late steps of cytokinesis. Indeed, we found that branched F-actin and Cofilin-1 were specifically required for the MT cut. This
**Fig. 6** | **Branched F-actin promotes abscission by favoring MT severing.** a Top: Staining of endogenous ARPC2, IST1 and Tubulin in a late ICB with secondary ingression (arrowhead). Scale bar = 2 µm. Bottom: Intensity profile of ARPC2 (magenta) and IST1 (green) between * and ** along the ICB from the top merge picture. This experiment was repeated at least three times independently with similar results. b Snapshots of a spinning disk confocal microscopy movie of cells stably co-expressing CHMP4B-GFP and mApple-ARPC4 and incubated with fluorescent SiR-Tubulin. Arrowheads: ARPC4 localization at the tip of the CHMP4B cone. Scale bar = 2 µm. c Left: Cumulative distribution of the fraction of cells that completed abscission (determined by phase contrast time-lapse microscopy) as function of time after complete furrow ingression in cells treated, after furrow ingression, with either DMSO or CK666 (n ≥ 195 cells per condition from 3 independent experiments). Note that DMSO and 160 µM CK666 were added after

furrow ingression in synchronized cells (see Methods). Right: Mean abscission time (min) ± SD in indicated cells, *n* ≥ 61 cells per condition, *N* = 3 independent experiments. Two-tailed unpaired Student's *t*-test. d Same analysis as in Fig. 4b in cells treated with either DMSO or CK666 after complete furrow ingression, as indicated. Left: *n* ≥ 150 cells per condition from 3 independent experiments. Middle and right: *n* ≥ 41 cells per condition, *N* = 3 independent experiments. Two-tailed paired Student's *t*-test. n.s. = non-significant (*p* > 0.05). e Same analysis as in Fig. 4d in cells treated with either DMSO or CK666, together with DMSO or 2 µM Batabulin after complete furrow ingression, as indicated. Left: *n* ≥ 89 cells per condition from 3 independent experiments. Right: *n* ≥ 21 cells per condition, *N* = 3 independent experiments. One-way ANOVA with Tukey's multiple comparisons test. n.s. = non-significant (*p* > 0.05).

reveals a crosstalk between the actin and MT cytoskeleton via ESCRT polymers. We conclude that cytokinetic abscission can be divided into two distinct steps, a MT cut and a membrane cut, which are controlled by distinct molecular machineries.

## Methods

### Cell cultures

HeLa CCL-2 (ATCC) and NIH3T3 cells were grown in Dulbecco's Modified Eagle Medium (DMEM) GlutaMax (31966; Gibco, Invitrogen Life Technologies) supplemented with 10% fetal bovine serum and 1× penicillin-streptomycin (Gibco) in 5% CO₂ at 37 °C. BMEL cells⁸⁰ were grown in RPMI 1640 GlutaMax medium (61870010; Gibco, Invitrogen Life Technologies) supplemented with 10% fetal bovine serum, 1× penicillin-streptomycin (Gibco), 50 ng·ml⁻¹ epidermal growth factor, 30 ng·ml⁻¹ insulin-like growth factor II (PeproTech), 10 ng·ml⁻¹ insulin (Roche) and cultured on Collagen I (BD Biosciences) coated dishes with 5% CO₂ at 37 °C. CHMP4B-LAP-GFP; Cofilin-1-LAP-GFP; Cofilin-1-LAP-GFP + LifeAct-mCherry; Cofilin-1-LAP-GFP + mApple-ARPC4; CHMP4B-LAP-GFP + mApple-ARPC4 and CHMP4B-LAP-GFP + LifeAct-mCherry stable cell lines were generated by lentiviral transduction of HeLa ATCC CCL-2 cells and selected by FACS. Cofilin-1-LAP-GFP + Tom20-anti-GFP nanobody-SNAP-DHFR<sub>F98</sub> stable cell lines were generated by electroporating HeLa ATCC cells stably expressing Cofilin-1-LAP-GFP (see above) with the corresponding plasmid described in ref. 49, followed by G418 selection (Gibco) and FACS. These cells were continuously grown with 10 µM TMP (Trimethoprim, Sigma Aldrich). HeLa cells that stably express doxycycline-inducible EGFP-spastin wild-type M87 were a kind gift from T. Kapoor and were described in ref. 56. EGFP-spastin expression was induced using 1 µg·ml⁻¹ doxycycline for 20–30 h before imaging. NIH3T3 cells that stably express GFP-ARPC5 were a kind gift from Alexis Gautreau. For Cytochalasin D (Sigma-Aldrich) treatment, cells were incubated with 0.4 µM of drugs for 60 min before fixation.

### Transfections, siRNAs and plasmid constructs

pEGFP-N1 human cofilin WT / S3A / S3E were a kind gift from James Bamburg (Addgene plasmid # 50859 / # 50860 / # 50861). Cofilin-1, CHMP4B, LifeAct and ARPC4 CDS cDNAs were subcloned into Gateway pENTR plasmids and introduced into transient expression vectors or lentiviral constructs by LR recombination (Thermo Fisher) to generate EGFP, mCherry or mApple fusion proteins. siRNA-resistant versions of Cofilin-1 have been obtained by mutating 6 bp of the siRNA-targeting sequence using QuickChange (Agilent). Plasmids were transiently transfected in HeLa cells for 48 h using X-tremeGENE 9 DNA reagent (Roche).

For silencing experiments, HeLa cells were transfected with 25 nM siRNAs (siCofilin-1) or 50 nM siRNAs (siSpastin) for 72 h using HiPerFect (Qiagen) or Lipofectamine RNAiMAX (Invitrogen), following the manufacturer's instructions. siRNAs against Luciferase (used as control, 5'CGUACGCGGAAUACUUCGA[dU][dU]3'), Cofilin-1 (5'CUCUAUGAUGCAACCUAU[dU][dU]3')⁸¹ and spastin (5'AAACGG

ACGUCUAUAAUGA[dU][dU]3')⁸² have been synthesized by Sigma. In rescue experiments, cells were first transfected for 72 h with siRNAs using HiPerFect, then transfected by plasmids encoding GFP or siRNA-resistant Cofilin-1-GFP wild type or mutant using DharmaFECT Duo transfection reagent (Dharmacon) for an additional 24 h.

### Western blots

Cells were lysed on ice for 30 min in NP-40 lysis buffer (50 mM Tris, pH 8, 150 mM NaCl, 1% NP-40 and protease inhibitors) and centrifuged at 10,000 g for 10 min. Migration of 20 µg of lysate supernatants was performed in 4–12% gradient or in 10% SDS-PAGE gels (Bio-Rad Laboratories), transferred onto PVDF membranes (Millipore), blocked and incubated with corresponding antibodies in 5% milk in 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% Tween20, followed by horseradish peroxidase-coupled secondary antibodies (1:10,000, Jackson ImmunoResearch) and revealed by chemiluminescence (GE Healthcare).

### Immunofluorescence and image acquisition

HeLa cells were grown on coverslips and fixed either with paraffin-alkoholde (PFA) 4% for 20 min at room temperature or with ice-cold methanol for 2–3 min (see Supplementary Table 1). Cells were then permeabilized with 0.1% Triton-X100 when necessary, blocked with PBS containing 1% bovine serum albumin (BSA) and successively incubated for 1 h at room temperature with primary (see Supplementary Table 1) and secondary antibodies (1:500, Jackson Laboratory) diluted in PBS containing 1% BSA before DAPI staining for 5 min (0.5 mg/ml, Serva). Cells were mounted in Fluoromount G (Southern Biotech). For endogenous staining of ARPC2, cells were first fixed with 4% PFA + 0.5% Triton-X100 for 1.5 min before incubation with 4% PFA for 15 min.

Images were acquired with an inverted TiE Nikon microscope, using a x60 or a ×100 1.4 NA PL-APO objective lens and MetaMorph software (MDS) driving either a CCD camera (Photometrics Coolsnap HQ) or a Retiga R6 CCD camera (Teledyne Photometrics). Alternatively, images were acquired on an inverted Nikon Eclipse TiE microscope equipped with a CSU-X1 spinning disk confocal scanning unit (Yokogawa) coupled to either a Prime 95 S scientific complementary metal-oxide semiconductor (sCMOS) camera (Teledyne Photometrics) or a EMCCD Camera (Evolve 512 Delta, Photometrics). Images were then converted into RGB 8-bit images using ImageJ software (NIH) and resampled to 300ppi using Adobe Photoshop (bicubic method).

## Image and data analysis

All images and movies were analyzed with the Fiji software. Mean intensity values were extracted from manually drawn ROIs for each channel of interest using Fiji and mean background intensity was subtracted. The scan lines were obtained using an ROI (straight line), with a width corresponding to the bridge after subtraction of the background intensity. Intensity values were normalized to control condition or to the maximal intensity measured as indicated in the
**Fig. 6** | **Branched F-actin promotes abscission by favoring MT severing.** a Top: Staining of endogenous ARPC2, IST1 and Tubulin in a late ICB with secondary ingression (arrowhead). Scale bar = 2 µm. Bottom: Intensity profile of ARPC2 (magenta) and IST1 (green) between * and ** along the ICB from the top merge picture. This experiment was repeated at least three times independently with similar results. b Snapshots of a spinning disk confocal microscopy movie of cells stably co-expressing CHMP4B-GFP and mApple-ARPC4 and incubated with fluorescent SiR-Tubulin. Arrowheads: ARPC4 localization at the tip of the CHMP4B cone. Scale bar = 2 µm. c Left: Cumulative distribution of the fraction of cells that completed abscission (determined by phase contrast time-lapse microscopy) as function of time after complete furrow ingression in cells treated, after furrow ingression, with either DMSO or CK666 (n ≥ 195 cells per condition from 3 independent experiments). Note that DMSO and 160 µM CK666 were added after

furrow ingression in synchronized cells (see Methods). Right: Mean abscission time (min) ± SD in indicated cells, *n* ≥ 61 cells per condition, *N* = 3 independent experiments. Two-tailed unpaired Student's *t*-test. d Same analysis as in Fig. 4b in cells treated with either DMSO or CK666 after complete furrow ingression, as indicated. Left: *n* ≥ 150 cells per condition from 3 independent experiments. Middle and right: *n* ≥ 41 cells per condition, *N* = 3 independent experiments. Two-tailed paired Student's *t*-test. n.s. = non-significant (*p* > 0.05). e Same analysis as in Fig. 4d in cells treated with either DMSO or CK666, together with DMSO or 2 µM Batabulin after complete furrow ingression, as indicated. Left: *n* ≥ 89 cells per condition from 3 independent experiments. Right: *n* ≥ 21 cells per condition, *N* = 3 independent experiments. One-way ANOVA with Tukey's multiple comparisons test. n.s. = non-significant (*p* > 0.05).

reveals a crosstalk between the actin and MT cytoskeleton via ESCRT polymers. We conclude that cytokinetic abscission can be divided into two distinct steps, a MT cut and a membrane cut, which are controlled by distinct molecular machineries.

## Methods

### Cell cultures

HeLa CCL-2 (ATCC) and NIH3T3 cells were grown in Dulbecco's Modified Eagle Medium (DMEM) GlutaMax (31966; Gibco, Invitrogen Life Technologies) supplemented with 10% fetal bovine serum and 1× penicillin-streptomycin (Gibco) in 5% CO₂ at 37 °C. BMEL cells⁸⁰ were grown in RPMI 1640 GlutaMax medium (61870010; Gibco, Invitrogen Life Technologies) supplemented with 10% fetal bovine serum, 1× penicillin-streptomycin (Gibco), 50 ng·ml⁻¹ epidermal growth factor, 30 ng·ml⁻¹ insulin-like growth factor II (PeproTech), 10 ng·ml⁻¹ insulin (Roche) and cultured on Collagen I (BD Biosciences) coated dishes with 5% CO₂ at 37 °C. CHMP4B-LAP-GFP; Cofilin-1-LAP-GFP; Cofilin-1-LAP-GFP + LifeAct-mCherry; Cofilin-1-LAP-GFP + mApple-ARPC4; CHMP4B-LAP-GFP + mApple-ARPC4 and CHMP4B-LAP-GFP + LifeAct-mCherry stable cell lines were generated by lentiviral transduction of HeLa ATCC CCL-2 cells and selected by FACS. Cofilin-1-LAP-GFP + Tom20-anti-GFP nanobody-SNAP-DHFR<sub>F98</sub> stable cell lines were generated by electroporating HeLa ATCC cells stably expressing Cofilin-1-LAP-GFP (see above) with the corresponding plasmid described in ref. 49, followed by G418 selection (Gibco) and FACS. These cells were continuously grown with 10 µM TMP (Trimethoprim, Sigma Aldrich). HeLa cells that stably express doxycycline-inducible EGFP-spasin wild-type M87 were a kind gift from T. Kapoor and were described in ref. 56. EGFP-spasin expression was induced using 1 µg·ml⁻¹ doxycycline for 20–30 h before imaging. NIH3T3 cells that stably express GFP-ARPC5 were a kind gift from Alexis Gautreau. For Cytochalasin D (Sigma-Aldrich) treatment, cells were incubated with 0.4 µM of drugs for 60 min before fixation.

### Transfections, siRNAs and plasmid constructs

pEGFP-N1 human cofilin WT / S3A / S3E were a kind gift from James Bamburg (Addgene plasmid # 50859 / # 50860 / # 50861). Cofilin-1, CHMP4B, LifeAct and ARPC4 CDS cDNAs were subcloned into Gateway pENTR plasmids and introduced into transient expression vectors or lentiviral constructs by LR recombination (Thermo Fisher) to generate EGFP, mCherry or mApple fusion proteins. siRNA-resistant versions of Cofilin-1 have been obtained by mutating 6 bp of the siRNA-targeting sequence using QuickChange (Agilent). Plasmids were transiently transfected in HeLa cells for 48 h using X-tremeGENE 9 DNA reagent (Roche).

For silencing experiments, HeLa cells were transfected with 25 nM siRNAs (siCofilin-1) or 50 nM siRNAs (siSpastin) for 72 h using HiPerFect (Qiagen) or Lipofectamine RNAiMAX (Invitrogen), following the manufacturer's instructions. siRNAs against Luciferase (used as control, 5'CGUACGCGGAAUACUUCGA[dU][dU]3'), Cofilin-1 (5'CUCUAUGAUGCAACCUAU[dU][dU]3')⁸¹ and spasin (5'AAACGG

ACGUCUAUAAUGA[dU][dU]3')⁸² have been synthesized by Sigma. In rescue experiments, cells were first transfected for 72 h with siRNAs using HiPerFect, then transfected by plasmids encoding GFP or siRNA-resistant Cofilin-1-GFP wild type or mutant using DharmaFECT Duo transfection reagent (Dharmacon) for an additional 24 h.

### Western blots

Cells were lysed on ice for 30 min in NP-40 lysis buffer (50 mM Tris, pH 8, 150 mM NaCl, 1% NP-40 and protease inhibitors) and centrifuged at 10,000 g for 10 min. Migration of 20 µg of lysate supernatants was performed in 4–12% gradient or in 10% SDS-PAGE gels (Bio-Rad Laboratories), transferred onto PVDF membranes (Millipore), blocked and incubated with corresponding antibodies in 5% milk in 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.1% Tween20, followed by horseradish peroxidase-coupled secondary antibodies (1:10,000, Jackson ImmunoResearch) and revealed by chemiluminescence (GE Healthcare).

### Immunofluorescence and image acquisition

HeLa cells were grown on coverslips and fixed either with paraffin-alkoholde (PFA) 4% for 20 min at room temperature or with ice-cold methanol for 2–3 min (see Supplementary Table 1). Cells were then permeabilized with 0.1% Triton-X100 when necessary, blocked with PBS containing 1% bovine serum albumin (BSA) and successively incubated for 1 h at room temperature with primary (see Supplementary Table 1) and secondary antibodies (1:500, Jackson Laboratory) diluted in PBS containing 1% BSA before DAPI staining for 5 min (0.5 mg/ml, Serva). Cells were mounted in Fluoromount G (Southern Biotech). For endogenous staining of ARPC2, cells were first fixed with 4% PFA + 0.5% Triton-X100 for 1.5 min before incubation with 4% PFA for 15 min.

Images were acquired with an inverted TiE Nikon microscope, using a x60 or a ×100 1.4 NA PL-APO objective lens and MetaMorph software (MDS) driving either a CCD camera (Photometrics Coolsnap HQ) or a Retiga R6 CCD camera (Teledyne Photometrics). Alternatively, images were acquired on an inverted Nikon Eclipse TiE microscope equipped with a CSU-X1 spinning disk confocal scanning unit (Yokogawa) coupled to either a Prime 95 S scientific complementary metal-oxide semiconductor (sCMOS) camera (Teledyne Photometrics) or a EMCCD Camera (Evolve 512 Delta, Photometrics). Images were then converted into RGB 8-bit images using ImageJ software (NIH) and resampled to 300ppi using Adobe Photoshop (bicubic method).

## Image and data analysis

All images and movies were analyzed with the Fiji software. Mean intensity values were extracted from manually drawn ROIs for each channel of interest using Fiji and mean background intensity was subtracted. The scan lines were obtained using an ROI (straight line), with a width corresponding to the bridge after subtraction of the background intensity. Intensity values were normalized to control condition or to the maximal intensity measured as indicated in the
<figure><img src="image_42.png" /><figcaption>CK666
GFP-spastin
SiR-Tubulin</figcaption></figure>

<figure><img src="image_43.png" /></figure>

<figure><img src="image_44.png" /><figcaption>b
spastin
Tubulin</figcaption></figure>

<figure><img src="image_45.png" /></figure>

<figure><img src="image_46.png" /><figcaption>c
CHMP4B-GFP
mApple-ARPC4
SiR-Tubulin</figcaption></figure>

<figure><img src="image_47.png" /><figcaption>d
CHMP4B-GFP
mApple-ARPC4
SiR-Tubulin</figcaption></figure>

<figure><img src="image_48.png" /><figcaption>e
Distance d midbody-CHMP4B tip (µm)

DMSO
CK666

Time (min)</figcaption></figure>

<figure><img src="image_49.png" /><figcaption>f
CHMP4B-GFP
mApple-ARPC4
SiR-Tubulin</figcaption></figure>

<figure><img src="image_50.png" /></figure>

figure legends. To measure the rate of CHMP4B cone growth, the size of the CHMP4B-GFP cone—from the midbody ring to the tip of the cone— was measured every 5–8 min using CHMP4B-GFP movies, from the appearance of the cone to the occurrence of the MT cut. The slope of the curve was used to determine the mean rate of ESCRT-III cone elongation.

Illustrations were created with BioRender.com.

Time-lapse microscopy

For time-lapse phase-contrast imaging, cells were plated for 48 h on glass bottom 12-well plates (MatTek) and put in an open chamber (Life Imaging) equilibrated in 5% CO₂ and maintained at 37 °C. Cells were
<figure><img src="image_42.png" /><figcaption>CK666
GFP-spastin
SiR-Tubulin</figcaption></figure>

<figure><img src="image_43.png" /></figure>

<figure><img src="image_44.png" /><figcaption>b
spastin
Tubulin</figcaption></figure>

<figure><img src="image_45.png" /></figure>

<figure><img src="image_46.png" /><figcaption>c
CHMP4B-GFP
mApple-ARPC4
SiR-Tubulin</figcaption></figure>

<figure><img src="image_47.png" /></figure>

<figure><img src="image_48.png" /><figcaption>d
CHMP4B-GFP
mApple-ARPC4
SiR-Tubulin</figcaption></figure>

<figure><img src="image_49.png" /></figure>

<figure><img src="image_50.png" /></figure>

<figure><img src="image_51.png" /></figure>

<figure><img src="image_52.png" /><figcaption>f
CHMP4B-GFP
mApple-ARPC4
SiR-Tubulin</figcaption></figure>

<figure><img src="image_53.png" /><figcaption>CK666
CHMP4B-GFP
mApple-ARPC4
SiR-Tubulin</figcaption></figure>

<figure><img src="image_54.png" /></figure>

figure legends. To measure the rate of CHMP4B cone growth, the size of the CHMP4B-GFP cone—from the midbody ring to the tip of the cone—was measured every 5–8 min using CHMP4B-GFP movies, from the appearance of the cone to the occurrence of the MT cut. The slope of the curve was used to determine the mean rate of ESCRT-III cone elongation.

Illustrations were created with BioRender.com.

## Time-lapse microscopy

For time-lapse phase-contrast imaging, cells were plated for 48 h on glass bottom 12-well plates (MatTek) and put in an open chamber (Life Imaging) equilibrated in 5% CO₂ and maintained at 37 °C. Cells were
**Fig. 7** | **Branched F-actin prevents excessive ESCRT-III cone elongation and promotes correct spastin localization.** a Left: Snapshots of a spinning disk confocal microscopy movie of cells stably expressing inducible GFP-spastin M87 and incubated with fluorescent SiR-Tubulin, either in the presence of DMSO or 200 µM CK666. Arrowheads: spastin at secondary ingressions. Scale bars= 5 µm. Right: Time (min) elapsed between spastin appearance at the cone and the MT cut. Mean ± SD in indicated cells, *n* = 30 (DMSO) or 24 (CK666) cells per condition from *N* = 4 independent experiments. Two-sided Mann-Whitney test. b Top: Staining of endogenous spastin and Tubulin in late ICBs with secondary ingression (arrowhead) after addition of either DMSO or 200 µM CK666. Scale bars = 5 µm. Bottom left: Mean intensity (arbitrary units) of spastin at the secondary ingression. The intensities are normalized in each experiment to the mean intensity of DMSO-treated cells. Mean ± SD, *n* = 12–43 cells per condition, *N* = 3 independent experiments (violin plots). Two-tailed unpaired Student's t-test with Welch's correction. n.s. = non-significant (*p* > 0.05). Bottom right: distance d (µm) between the center of the midbody and the tip of the spastin labelling. Mean ± SD, *n* = 9–38 cells per condition, *N* = 3 independent experiments (violin plots). Two-tailed unpaired Student's t-test. c Top: Staining of endogenous CHMP1B and Tubulin in late ICBs with secondary ingression after addition of either DMSO or 200 µM CK666. Arrowheads: tip of the CHMP1B cone. Scale bars = 5 µm. Bottom: distance d (µm) between

the center of the midbody and the tip of the CHMP1B cone. Mean ± SD, *n* = 12–23 cells per condition, *N* = 3 independent experiments (violin plots). Two-tailed unpaired Student's t-test. d Snapshots of a spinning disk confocal microscopy movie of cells stably co-expressing CHMP4B-GFP and mApple-ARPC4, incubated with fluorescent SiR-Tubulin and treated with DMSO added between *t* = 0 and *t* = 5 min. Arrowheads: ARPC4 localization at the tip of the CHMP4B cone. Scale bar = 2 µm. e (i) Distance d (µm) between the center of the midbody and the tip of the CHMP4B-GFP cone as a function of time from cells recorded as in (d) and treated with either DMSO (black curves) or 200 µM CK666 (green curves). Each line represents a single cell and only cells displaying a dot of ARPC4 at the tip of the CHMP4B cone at the beginning of the movies (*t* = 0 min) were depicted. Drugs were added between *t* = 0 and *t* = 5 min. *n* = 15 (DMSO) or 27 (CK666) cells. The last point of each curve corresponds to the time of the MT cut. (ii) Time (min) between the start of the movies described in (i) and the MT cut. Mean ± SD, *n* = 15 (DMSO) or 27 (CK666) cells. Two-sided Mann-Whitney test. (iii) Distance d between the center of the midbody and the tip of the CHMP4B-GFP cone at the timepoint preceding the MT cut from movies described in (i). Mean ± SD, *n* = 15 (DMSO) or 27 (CK666) cells. Two-sided Mann-Whitney test. f Same as in (d) but after treatment with 200 µM CK666. Scale bar = 2 µm.

<figure><img src="image_51.png" /></figure>

**Fig. 8** | **Model: control of cytokinetic abscission by Cofilin-1, Arp2/3 and branched F-actin-dependent MT severing.** Both Cofilin-1 and Arp2/3 promote abscission by regulating the cut of the ICB MTs at the secondary ingression. Cofilin-1 controls the growth rate of the ESCRT-III cone and the disassembly of a transient pool of Arp2/3-mediated branched F-actin at the tip of the ESCRT-III cone at the secondary ingression at the time of the MT cut. In the absence of Cofilin-1, this pool

stays longer, the ESCRT-III cone elongation is slowed down and CHMP1B-dependent recruitment of spastin is reduced. In the absence of Arp2/3, the ESCRT-III cone continuously extends away from the midbody which impairs stable spastin recruitment and leads to abscission defects due to delayed MT severing. We propose that Arp2/3 limits the extension of the ESCRT-III cone by acting as a physical barrier at the secondary ingression, thus favoring the MT cut.

recorded every 10 min for 48 h using an inverted Nikon Eclipse TiE microscope with a ×20 0.45 NA Plan Fluor ELWD or a ×40 0.95 NA PL-APO objectives controlled by Metamorph software (Universal Imaging).

To determine abscission times, we used the phase contrast channel and measured the time elapsed from the first image after complete furrow ingression until the occurrence of the membrane cut of the ICB, which is usually accompanied by a sudden change in orientation of the midbody. To determine the MT cut time, the culture medium was replaced and 25–100 nM of fluorescent SiR-tubulin (SC002, Spirochrome) were added at least 6 h before recording. We then measured both the MT cut and the membrane cut in the same cells, starting from complete furrow ingression up to the occurrence of the first cut of the microtubules on one side of the midbody visualized by the SiR-tubulin signal in the fluorescent channel.

Drugs were added (2 µM Batabulin or 160 µM CK666) or washed out (10 µM TMP = Trimethoprim) after complete furrow ingression using two protocols: In Figs. 4d, 6d, e, S5c and S5d mitotic cells were randomly picked and recorded for 24 h every 10 min and drugs were added between timepoint 30 and 40 min, thus after completion of furrow ingression; In Figs. 2e and 6c, cells were synchronized by mitotic shake: from 80% confluent flasks, a first mitotic shake was performed to remove debris and dead cells. One hour later, a second mitotic shake was performed to harvest mitotic cells. Metaphase cells were then plated on a collagen-coated glass surface and let to adhere at 37 °C. Next, the medium with or without drugs was changed and cells were recorded 60 min after replating every 10 min for 24 h on randomly picked cells. Only cells with already fully ingressed furrow were analyzed (Figs. 2e and 6c).

To visualize protein localization by time-lapse fluorescent microscopy, cells were recorded with an inverted Nikon Eclipse Ti-E
**Fig. 7** | **Branched F-actin prevents excessive ESCRT-III cone elongation and promotes correct spastin localization.** a Left: Snapshots of a spinning disk confocal microscopy movie of cells stably expressing inducible GFP-spastin M87 and incubated with fluorescent SiR-Tubulin, either in the presence of DMSO or 200 µM CK666. Arrowheads: spastin at secondary ingressions. Scale bars= 5 µm. Right: Time (min) elapsed between spastin appearance at the cone and the MT cut. Mean ± SD in indicated cells, *n* = 30 (DMSO) or 24 (CK666) cells per condition from *N* = 4 independent experiments. Two-sided Mann-Whitney test. b Top: Staining of endogenous spastin and Tubulin in late ICBs with secondary ingression (arrow-head) after addition of either DMSO or 200 µM CK666. Scale bars = 5 µm. Bottom left: Mean intensity (arbitrary units) of spastin at the secondary ingression. The intensities are normalized in each experiment to the mean intensity of DMSO-treated cells. Mean ± SD, *n* = 12–43 cells per condition, *N* = 3 independent experiments (violin plots). Two-tailed unpaired Student's t-test with Welch's correction. n.s. = non-significant (*p* > 0.05). Bottom right: distance d (µm) between the center of the midbody and the tip of the spastin labelling. Mean ± SD, *n* = 9–38 cells per condition, *N* = 3 independent experiments (violin plots). Two-tailed unpaired Student's t-test. c Top: Staining of endogenous CHMP1B and Tubulin in late ICBs with secondary ingression after addition of either DMSO or 200 µM CK666. Arrowheads: tip of the CHMP1B cone. Scale bars = 5 µm. Bottom: distance d (µm) between

the center of the midbody and the tip of the CHMP1B cone. Mean ± SD, *n* = 12–23 cells per condition, *N* = 3 independent experiments (violin plots). Two-tailed unpaired Student's t-test. d Snapshots of a spinning disk confocal microscopy movie of cells stably co-expressing CHMP4B-GFP and mApple-ARPC4, incubated with fluorescent SiR-Tubulin and treated with DMSO added between *t* = 0 and *t* = 5 min. Arrowheads: ARPC4 localization at the tip of the CHMP4B cone. Scale bar = 2 µm. e (i) Distance d (µm) between the center of the midbody and the tip of the CHMP4B-GFP cone as a function of time from cells recorded as in (d) and treated with either DMSO (black curves) or 200 µM CK666 (green curves). Each line represents a single cell and only cells displaying a dot of ARPC4 at the tip of the CHMP4B cone at the beginning of the movies (*t* = 0 min) were depicted. Drugs were added between *t* = 0 and *t* = 5 min. *n* = 15 (DMSO) or 27 (CK666) cells. The last point of each curve corresponds to the time of the MT cut. (ii) Time (min) between the start of the movies described in (i) and the MT cut. Mean ± SD, *n* = 15 (DMSO) or 27 (CK666) cells. Two-sided Mann-Whitney test. (iii) Distance d between the center of the midbody and the tip of the CHMP4B-GFP cone at the timepoint preceding the MT cut from movies described in (i). Mean ± SD, *n* = 15 (DMSO) or 27 (CK666) cells. Two-sided Mann-Whitney test. f Same as in (d) but after treatment with 200 µM CK666. Scale bar = 2 µm.

<figure><img src="image_55.png" /></figure>

**Fig. 8** | **Model: control of cytokinetic abscission by Cofilin-1, Arp2/3 and branched F-actin-dependent MT severing.** Both Cofilin-1 and Arp2/3 promote abscission by regulating the cut of the ICB MTs at the secondary ingression. Cofilin-1 controls the growth rate of the ESCRT-III cone and the disassembly of a transient pool of Arp2/3-mediated branched F-actin at the tip of the ESCRT-III cone at the secondary ingression at the time of the MT cut. In the absence of Cofilin-1, this pool

stays longer, the ESCRT-III cone elongation is slowed down and CHMP1B-dependent recruitment of spastin is reduced. In the absence of Arp2/3, the ESCRT-III cone continuously extends away from the midbody which impairs stable spastin recruitment and leads to abscission defects due to delayed MT severing. We propose that Arp2/3 limits the extension of the ESCRT-III cone by acting as a physical barrier at the secondary ingression, thus favoring the MT cut.

recorded every 10 min for 48 h using an inverted Nikon Eclipse TiE microscope with a ×20 0.45 NA Plan Fluor ELWD or a ×40 0.95 NA PL-APO objectives controlled by Metamorph software (Universal Imaging).

To determine abscission times, we used the phase contrast channel and measured the time elapsed from the first image after complete furrow ingression until the occurrence of the membrane cut of the ICB, which is usually accompanied by a sudden change in orientation of the midbody. To determine the MT cut time, the culture medium was replaced and 25–100 nM of fluorescent SiR-tubulin (SC002, Spirochrome) were added at least 6 h before recording. We then measured both the MT cut and the membrane cut in the same cells, starting from complete furrow ingression up to the occurrence of the first cut of the microtubules on one side of the midbody visualized by the SiR-tubulin signal in the fluorescent channel.

Drugs were added (2 µM Batabulin or 160 µM CK666) or washed out (10 µM TMP = Trimethoprim) after complete furrow ingression using two protocols: In Figs. 4d, 6d, e, S5c and S5d mitotic cells were randomly picked and recorded for 24 h every 10 min and drugs were added between timepoint 30 and 40 min, thus after completion of furrow ingression; In Figs. 2e and 6c, cells were synchronized by mitotic shake: from 80% confluent flasks, a first mitotic shake was performed to remove debris and dead cells. One hour later, a second mitotic shake was performed to harvest mitotic cells. Metaphase cells were then plated on a collagen-coated glass surface and let to adhere at 37 °C. Next, the medium with or without drugs was changed and cells were recorded 60 min after replating every 10 min for 24 h on randomly picked cells. Only cells with already fully ingressed furrow were analyzed (Figs. 2e and 6c).

To visualize protein localization by time-lapse fluorescent microscopy, cells were recorded with an inverted Nikon Eclipse Ti-E
microscope equipped with a CSU-X1 spinning disk confocal scanning unit (Yokogawa) and with either an EMCCD (Evolve 512 Delta, Photometrics) or a Prime 95 S sCMOS camera (Teledyne Photometrics). Images were acquired with 100 × 1.4 NA PL-APO or 60 × 1.4 NA PL-APO VC objectives and MetaMorph software (MDS). 25–100 nM of fluorescent SiR-Tubulin were added and incubated at least 6 h before recording. SNAP-Cell 647-SiR substrate (S9102S New England Biolabs) was used to reveal SNAP-tag following the manufacturer's instructions. For live cell experiment presented Fig. 7a, d, f DMSO or 200 µM CK666 was added between the first and the second timepoint after starting the acquisition.

## Statistical analyses

All plots and statistical tests were performed using the GraphPad Prism software. The presented values are displayed as mean ± SD from at least three independent experiments and the test used is indicated in the figure legends. In all statistical tests, *p*-value > 0.05 was considered as nonsignificant. *P*-values are indicated in the figures.

## Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

## Data availability

All data are available in the main text or the supplementary materials. Uncropped gels are presented in the Source Data file and in Supplementary Fig. 7. All reagents described in this paper will be made available to readers and be sent upon request. Source data are provided with this paper.

## References

1. Green, R. A., Paluch, E. & Oegema, K. Cytokinesis in Animal Cells. *Ann. Rev. Cell Dev. Biol.* (2012).

2. D'Avino, P. P., Giansanti, M. G. & Petronczki, M. Cytokinesis in animal cells. *Cold Spring Harbor Persp. Biol.* **7**, a015834 (2015).

3. Mierzwa, B. & Gerlich, D. W. Cytokinetic Abscission: Molecular Mechanisms and Temporal Control. *Dev. Cell* **31**, 525–538 (2014).

4. D'Avino, P. P. & Capalbo, L. Regulation of midbody formation and function by mitotic kinases. *Semin. Cell Dev. Biol.* **53**, 57–63 (2016).

5. Fremont, S. & Echard, A. Membrane Traffic in the Late Steps of Cytokinesis. *Curr. Biol.: CB* **28**, R458–R470 (2018).

6. Scourfield, E. J. & Martin-Serrano, J. Growing functions of the ESCRT machinery in cell biology and viral replication. *Biochem. Soc. Transac.* **45**, 613–634 (2017).

7. Stoten, C. L. & Carlton, J. G. ESCRT-dependent control of membrane remodelling during cell division. *Semin. Cell Develop. Biol.* **74**, 50–65 (2017).

8. McCullough, J., Frost, A. & Sundquist, W. I. Structures, Functions, and Dynamics of ESCRT-III/Vps4 Membrane Remodeling and Fission Complexes. *Ann. Rev. cell Dev. Biol.* **34**, 85–109 (2018).

9. Remec Pavlin, M. & Hurley, J. H. The ESCRTs - converging on mechanism. *J Cell Sci.* **133**, jcs240333 (2020).

10. Vietri, M., Radulovic, M. & Stenmark, H. The many functions of ESCRTs. *Nat. Rev. Mol. Cell Biol.* **21**, 25–42 (2020).

11. Carlton, J. G. & Martin-Serrano, J. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. *Science* **316**, 1908–1912 (2007).

12. Morita, E. et al. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. *EMBO J.* **26**, 4215–4227 (2007).

13. Guizetti, J. et al. Cortical Constriction During Abscission Involves Helices of ESCRT-III-Dependent Filaments. *Science* **331**, 1616–1620 (2011).

14. Konig, J., Frankel, E. B., Audhya, A. & Muller-Reichert, T. Membrane remodeling during embryonic abscission in Caenorhabditis elegans. *J. Cell Biol.* **216**, 1277–1286 (2017).

15. Goliand, I. et al. Resolving ESCRT-III Spirals at the Intercellular Bridge of Dividing Cells Using 3D STORM. *Cell Rep.* **24**, 1756–1764 (2018).

16. Addi, C., Bai, J. & Echard, A. Actin, microtubule, septin and ESCRT filament remodeling during late steps of cytokinesis. *Curr. Opin. Cell Biol.* **50**, 27–34 (2018).

17. Andrade, V. & Echard, A. Mechanics and regulation of cytokinetic abscission. *Front. Cell Dev. Biol.* **10**, 1046617 (2022).

18. Elia, N., Sougrat, R., Spurlin, T. A., Hurley, J. H. & Lippincott-Schwartz, J. Dynamics of endosomal sorting complex required for transport (ESCRT) machinery during cytokinesis and its role in abscission. *Proc. Natl. Acad. Sci. USA* **108**, 4846–4851 (2011).

19. Schiel, J. A. et al. FIP3-endosome-dependent formation of the secondary ingression mediates ESCRT-III recruitment during cytokinesis. *Nat. Cell Biol.* **14**, 1068–1078 (2012).

20. Renshaw, M. J., Liu, J., Lavoie, B. D. & Wilde, A. Anillin-dependent organization of septin filaments promotes intercellular bridge elongation and Chmp4B targeting to the abscission site. *Open Biol.* **4**, 130190 (2014).

21. Addi, C. et al. The Flemmingsome reveals an ESCRT-to-membrane coupling via ALIX/syntenin/syndecan-4 required for completion of cytokinesis. *Nat. Commun.* **11**, 1941 (2020).

22. Andrade, V. et al. Caveolae promote successful abscission by controlling intercellular bridge tension during cytokinesis. *Sci. Adv.* **8**, eabm5095 (2022).

23. McNeely, K. C. & Dwyer, N. D. Cytokinetic Abscission Regulation in Neural Stem Cells and Tissue Development. *Curr. Stem Cell Rep.* **7**, 161–173 (2021).

24. Farmer, T. & Prekeris, R. New signaling kid on the block: the role of the postmitotic midbody in polarity, stemness, and proliferation. *Mol. Biol. Cell* **33**, pe2 (2022).

25. Yang, D. et al. Structural basis for midbody targeting of spastin by the ESCRT-III protein CHMP1B. *mNat. Struc. Mol. Biol.* **15**, 1278–1286 (2008).

26. Connell, J. W., Lindon, C., Luzio, J. P. & Reid, E. Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion. *Traffic* **10**, 42–56 (2009).

27. Lafaurie-Janvore, J. et al. ESCRT-III assembly and cytokinetic abscission are induced by tension release in the intercellular bridge. *Science* **339**, 1625–1629 (2013).

28. Dambournet, D. et al. Rab35 GTPase and OCRL phosphatase remodel lipids and F-actin for successful cytokinesis. *Nat. Cell Biol.* **13**, 981–988 (2011).

29. Fremont, S. et al. Oxidation of F-actin controls the terminal steps of cytokinesis. *Nat. Commun.* **8**, 14528 (2017).

30. Bai, J. et al. Actin reduction by MsrB2 is a key component of the cytokinetic abscission checkpoint and prevents tetraploidy. *Proc. Natl. Acad. Sci. USA* **117**, 4169–4179 (2020).

31. Niu, F., Sun, K., Wei, W., Yu, C. & Wei, Z. F-actin disassembly factor MICAL1 binding to Myosin Va mediates cargo unloading during cytokinesis. *Sci Adv.* **6**, eabb1307 (2020).

32. Iannantuono, N. V. G. & Emery, G. Rab11FIP1 maintains Rab35 at the intercellular bridge to promote actin removal and abscission. *J. Cell Sci.* **134**, jcs244384 (2021).

33. Terry, S. J., Dona, F., Osenberg, P., Carlton, J. G. & Eggert, U. S. Capping protein regulates actin dynamics during cytokinetic midbody maturation. *Proc. Natl. Acad. Sci. USA* **115**, 2138–2143 (2018).

34. Dema, A. et al. Citron kinase-dependent F-actin maintenance at midbody secondary ingression sites mediates abscission. *J. Cell Sci.* **131**, jcs209080 (2018).
microscope equipped with a CSU-X1 spinning disk confocal scanning unit (Yokogawa) and with either an EMCCD (Evolve 512 Delta, Photometrics) or a Prime 95 S sCMOS camera (Teledyne Photometrics). Images were acquired with 100 × 1.4 NA PL-APO or 60 × 1.4 NA PL-APO VC objectives and MetaMorph software (MDS). 25–100 nM of fluorescent SiR-Tubulin were added and incubated at least 6 h before recording. SNAP-Cell 647-SiR substrate (S9102S New England Biolabs) was used to reveal SNAP-tag following the manufacturer's instructions. For live cell experiment presented Fig. 7a, d, f DMSO or 200 µM CK666 was added between the first and the second timepoint after starting the acquisition.

## Statistical analyses

All plots and statistical tests were performed using the GraphPad Prism software. The presented values are displayed as mean ± SD from at least three independent experiments and the test used is indicated in the figure legends. In all statistical tests, *p*-value > 0.05 was considered as nonsignificant. *P*-values are indicated in the figures.

## Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

## Data availability

All data are available in the main text or the supplementary materials. Uncropped gels are presented in the Source Data file and in Supplementary Fig. 7. All reagents described in this paper will be made available to readers and be sent upon request. Source data are provided with this paper.

## References

1. Green, R. A., Paluch, E. & Oegema, K. Cytokinesis in Animal Cells. *Ann. Rev. Cell Dev. Biol.* (2012).

2. D'Avino, P. P., Giansanti, M. G. & Petronczki, M. Cytokinesis in animal cells. *Cold Spring Harbor Persp. Biol.* **7**, a015834 (2015).

3. Mierzwa, B. & Gerlich, D. W. Cytokinetic Abscission: Molecular Mechanisms and Temporal Control. *Dev. Cell* **31**, 525–538 (2014).

4. D'Avino, P. P. & Capalbo, L. Regulation of midbody formation and function by mitotic kinases. *Semin. Cell Dev. Biol.* **53**, 57–63 (2016).

5. Fremont, S. & Echard, A. Membrane Traffic in the Late Steps of Cytokinesis. *Curr. Biol.: CB* **28**, R458–R470 (2018).

6. Scourfield, E. J. & Martin-Serrano, J. Growing functions of the ESCRT machinery in cell biology and viral replication. *Biochem. Soc. Transac.* **45**, 613–634 (2017).

7. Stoten, C. L. & Carlton, J. G. ESCRT-dependent control of membrane remodelling during cell division. *Semin. Cell Develop. Biol.* **74**, 50–65 (2017).

8. McCullough, J., Frost, A. & Sundquist, W. I. Structures, Functions, and Dynamics of ESCRT-III/Vps4 Membrane Remodeling and Fission Complexes. *Ann. Rev. cell Dev. Biol.* **34**, 85–109 (2018).

9. Remec Pavlin, M. & Hurley, J. H. The ESCRTs - converging on mechanism. *J Cell Sci.* **133**, jcs240333 (2020).

10. Vietri, M., Radulovic, M. & Stenmark, H. The many functions of ESCRTs. *Nat. Rev. Mol. Cell Biol.* **21**, 25–42 (2020).

11. Carlton, J. G. & Martin-Serrano, J. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. *Science* **316**, 1908–1912 (2007).

12. Morita, E. et al. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. *EMBO J.* **26**, 4215–4227 (2007).

13. Guizetti, J. et al. Cortical Constriction During Abscission Involves Helices of ESCRT-III-Dependent Filaments. *Science* **331**, 1616–1620 (2011).

14. Konig, J., Frankel, E. B., Audhya, A. & Muller-Reichert, T. Membrane remodeling during embryonic abscission in Caenorhabditis elegans. *J. Cell Biol.* **216**, 1277–1286 (2017).

15. Goliand, I. et al. Resolving ESCRT-III Spirals at the Intercellular Bridge of Dividing Cells Using 3D STORM. *Cell Rep.* **24**, 1756–1764 (2018).

16. Addi, C., Bai, J. & Echard, A. Actin, microtubule, septin and ESCRT filament remodeling during late steps of cytokinesis. *Curr. Opin. Cell Biol.* **50**, 27–34 (2018).

17. Andrade, V. & Echard, A. Mechanics and regulation of cytokinetic abscission. *Front. Cell Dev. Biol.* **10**, 1046617 (2022).

18. Elia, N., Sougrat, R., Spurlin, T. A., Hurley, J. H. & Lippincott-Schwartz, J. Dynamics of endosomal sorting complex required for transport (ESCRT) machinery during cytokinesis and its role in abscission. *Proc. Natl. Acad. Sci. USA* **108**, 4846–4851 (2011).

19. Schiel, J. A. et al. FIP3-endosome-dependent formation of the secondary ingression mediates ESCRT-III recruitment during cytokinesis. *Nat. Cell Biol.* **14**, 1068–1078 (2012).

20. Renshaw, M. J., Liu, J., Lavoie, B. D. & Wilde, A. Anillin-dependent organization of septin filaments promotes intercellular bridge elongation and Chmp4B targeting to the abscission site. *Open Biol.* **4**, 130190 (2014).

21. Addi, C. et al. The Flemmingsome reveals an ESCRT-to-membrane coupling via ALIX/syntenin/syndecan-4 required for completion of cytokinesis. *Nat. Commun.* **11**, 1941 (2020).

22. Andrade, V. et al. Caveolae promote successful abscission by controlling intercellular bridge tension during cytokinesis. *Sci. Adv.* **8**, eabm5095 (2022).

23. McNeely, K. C. & Dwyer, N. D. Cytokinetic Abscission Regulation in Neural Stem Cells and Tissue Development. *Curr. Stem Cell Rep.* **7**, 161–173 (2021).

24. Farmer, T. & Prekeris, R. New signaling kid on the block: the role of the postmitotic midbody in polarity, stemness, and proliferation. *Mol. Biol. Cell* **33**, pe2 (2022).

25. Yang, D. et al. Structural basis for midbody targeting of spastin by the ESCRT-III protein CHMP1B. *mNat. Struc. Mol. Biol.* **15**, 1278–1286 (2008).

26. Connell, J. W., Lindon, C., Luzio, J. P. & Reid, E. Spastin couples microtubule severing to membrane traffic in completion of cytokinesis and secretion. *Traffic* **10**, 42–56 (2009).

27. Lafaurie-Janvore, J. et al. ESCRT-III assembly and cytokinetic abscission are induced by tension release in the intercellular bridge. *Science* **339**, 1625–1629 (2013).

28. Dambournet, D. et al. Rab35 GTPase and OCRL phosphatase remodel lipids and F-actin for successful cytokinesis. *Nat. Cell Biol.* **13**, 981–988 (2011).

29. Fremont, S. et al. Oxidation of F-actin controls the terminal steps of cytokinesis. *Nat. Commun.* **8**, 14528 (2017).

30. Bai, J. et al. Actin reduction by MsrB2 is a key component of the cytokinetic abscission checkpoint and prevents tetraploidy. *Proc. Natl. Acad. Sci. USA* **117**, 4169–4179 (2020).

31. Niu, F., Sun, K., Wei, W., Yu, C. & Wei, Z. F-actin disassembly factor MICAL1 binding to Myosin Va mediates cargo unloading during cytokinesis. *Sci. Adv.* **6**, eabb1307 (2020).

32. Iannantuono, N. V. G. & Emery, G. Rab11FIP1 maintains Rab35 at the intercellular bridge to promote actin removal and abscission. *J. Cell Sci.* **134**, jcs244384 (2021).

33. Terry, S. J., Dona, F., Osenberg, P., Carlton, J. G. & Eggert, U. S. Capping protein regulates actin dynamics during cytokinetic midbody maturation. *Proc. Natl. Acad. Sci. USA* **115**, 2138–2143 (2018).

34. Dema, A. et al. Citron kinase-dependent F-actin maintenance at midbody secondary ingression sites mediates abscission. *J. Cell Sci.* **131**, jcs209080 (2018).
35. Gunsalus, K. C. et al. Mutations in twinstar, a Drosophila gene encoding a cofilin/ADF homologue, result in defects in centrosome migration and cytokinesis. *J. Cell Biol.* **131**, 1243–1259 (1995).

36. Somma, M. P., Fasulo, B., Cenci, G., Cundari, E. & Gatti, M. Molecular dissection of cytokinesis by RNA interference in Drosophila cultured cells. *Mol. Biol. Cell* **13**, 2448–2460 (2002).

37. Ono, K., Parast, M., Alberico, C., Benian, G. M. & Ono, S. Specific requirement for two ADF/cofilin isoforms in distinct actin-dependent processes in Caenorhabditis elegans. *J Cell Sci* **116**, 2073–2085 (2003).

38. Hotulainen, P., Paunola, E., Vartiainen, M. K. & Lappalainen, P. Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in mammalian nonmuscle cells. *Mol. Biol. Cell* **16**, 649–664 (2005).

39. Murthy, K. & Wadsworth, P. Myosin-II-dependent localization and dynamics of F-actin during cytokinesis. *Curr. Biol.*: CB **15**, 724–731 (2005).

40. Wiggan, O., Shaw, A. E., DeLuca, J. G. & Bamburg, J. R. ADF/cofilin regulates actomyosin assembly through competitive inhibition of myosin II binding to F-actin. *Dev. Cell* **22**, 530–543 (2012).

41. Xue, Z. & Sokac, A. M. - Back-to-back mechanisms drive actomyosin ring closure during Drosophila embryo cleavage. *J. Cell Biol.* **215**, 335–344 (2016).

42. Presle, A. et al. The viral restriction factor tetherin/BST2 tethers cytokinetic midbody remnants to the cell surface. *Curr. Biol.*: CB **31**, 2203–2213.e2205 (2021).

43. Nagaoka, R., Abe, H., Kusano, K. & Obinata, T. Concentration of cofilin, a small actin-binding protein, at the cleavage furrow during cytokinesis. *Cell Motil Cytoskeleton* **30**, 1–7 (1995).

44. Arber, S. et al. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. *Nature* **393**, 805–809 (1998).

45. Moriyama, K., Iida, K. & Yahara, I. Phosphorylation of Ser-3 of cofilin regulates its essential function on actin. *Genes Cells* **1**, 73–86 (1996).

46. Elam, W. A. et al. Phosphomimetic S3D cofilin binds but only weakly severs actin filaments. *J. Biol. Chem.* **292**, 19565–19579 (2017).

47. Wioland, H. et al. ADF/Cofilin Accelerates Actin Dynamics by Severing Filaments and Promoting Their Depolymerization at Both Ends. *Current biology: CB* **27**, 1956–1967.e1957 (2017).

48. Abe, H., Obinata, T., Minamide, L. S. & Bamburg, J. R. Xenopus laevis actin-depolymerizing factor/cofilin: a phosphorylation-regulated protein essential for development. *The J. Cell Biol.* **132**, 871–885 (1996).

49. Farrants, H. et al. Chemogenetic Control of Nanobodies. *Nat. Methods* **17**, 279–282 (2020).

50. Machesky, L. M. et al. Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex. *Proc. Natl. Acad. Sci USA* **96**, 3739–3744 (1999).

51. Welch, M. D. & Way, M. Arp2/3-mediated actin-based motility: a tail of pathogen abuse. *Cell host microbe* **14**, 242–255 (2013).

52. Abella, J. V. et al. Isoform diversity in the Arp2/3 complex determines actin filament dynamics. *Nat. Cell Biol.* **18**, 76–86 (2016).

53. Gautreau, A. M., Fregoso, F. E., Simanov, G. & Dominguez, R. Nucleation, stabilization, and disassembly of branched actin networks. *Trends Cell Biol.* **32**, 421–432 (2022).

54. Lappalainen, P., Kotila, T., Jégou, A. & Romet-Lemonne, G. Biochemical and mechanical regulation of actin dynamics. *Nat. Rev. Mol. Cell Biol.* **23**, 836–852 (2022).

55. Wagner, A. R., Luan, Q., Liu, S. L. & Nolen, B. J. Dip1 defines a class of Arp2/3 complex activators that function without preformed actin filaments. *Curr. Biol.*: CB **23**, 1990–1998 (2013).

56. Cupido, T., Pisa, R., Kelley, M. E. & Kapoor, T. M. Designing a chemical inhibitor for the AAA protein spastin using active site mutations. *Nat. Chem. Biol.* **15**, 444–452 (2019).

57. Carlton, J. G., Caballe, A., Agromayor, M., Kloc, M. & Martin-Serrano, J. ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. *Science* **336**, 220–225 (2012).

58. Caballe, A. et al. ULK3 regulates cytokinetic abscission by phosphorylating ESCRT-III proteins. *eLife* **4**, e06547 (2015).

59. Christ, L. et al. ALIX and ESCRT-I/II function as parallel ESCRT-III recruiters in cytokinetic abscission. *J. Cell Biol.* **212**, 499–513 (2016).

60. Mierzwa, B. E. et al. Dynamic subunit turnover in ESCRT-III assemblies is regulated by Vps4 to mediate membrane remodelling during cytokinesis. *Nat. Cell Biol.* **19**, 787–798 (2017).

61. Chaigne, A. et al. Abscission Couples Cell Division to Embryonic Stem Cell Fate. *Dev. Cell* **5**, 195–208.e195 (2020).

62. Strohacker, L. K. et al. Identification of abscission checkpoint bodies as structures that regulate ESCRT factors to control abscission timing. *eLife* **10**, e63743 (2021).

63. Steigemann, P. et al. Aurora B-mediated abscission checkpoint protects against tetraploidization. *Cell* **136**, 473–484 (2009).

64. Kouranti, I., Sachse, M., Arouche, N., Goud, B. & Echard, A. Rab35 regulates an endocytic recycling pathway essential for the terminal steps of cytokinesis. *Curr. Biol.*: CB **16**, 1719–1725 (2006).

65. Mathieu, J. et al. Aurora B and cyclin B have opposite effects on the timing of cytokinesis abscission in Drosophila germ cells and in vertebrate somatic cells. *Dev. Cell* **26**, 250–265 (2013).

66. Wang, K., Wloka, C. & Bi, E. Non-muscle Myosin-II Is Required for the Generation of a Constriction Site for Subsequent Abscission. *iScience* **13**, 69–81 (2019).

67. Spector, I., Shochet, N. R., Blasberger, D. & Kashman, Y. Latrunculins–novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D. *Cell Motil. Cytoskeleton* **13**, 127–144 (1989).

68. Wolter, P. et al. GAS2L3, a target gene of the DREAM complex, is required for proper cytokinesis and genomic stability. *J. Cell Sci.* **125**, 2393–2406 (2012).

69. Pe'er, T. et al. Gas2l3, a novel constriction site-associated protein whose regulation is mediated by the APC/C Cdh1 complex. *PloS one* **8**, e57532 (2013).

70. Capalbo, L. et al. The midbody interactome reveals unexpected roles for PP1 phosphatases in cytokinesis. *Nat. Commun.* **10**, 4513 (2019).

71. Blanchoin, L., Pollard, T. D. & Mullins, R. D. Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks. *Curr. Biol.*: CB **10**, 1273–1282 (2000).

72. Prochniewicz, E., Janson, N., Thomas, D. D. & De la Cruz, E. M. Cofilin increases the torsional flexibility and dynamics of actin filaments. *J. Mol. Biol.* **353**, 990–1000 (2005).

73. Andrianantoandro, E. & Pollard, T. D. Mechanism of actin filament turnover by severing and nucleation at different concentrations of ADF/cofilin. *Mol. Cell* **24**, 13–23 (2006).

74. Chan, C., Beltzner, C. C. & Pollard, T. D. Cofilin dissociates Arp2/3 complex and branches from actin filaments. *Curr. Biol.*: CB **19**, 537–545 (2009).

75. Wioland, H., Jegou, A. & Romet-Lemonne, G. Torsional stress generated by ADF/cofilin on cross-linked actin filaments boosts their severing. *Proc. Natl. Acad. Sci. USA* **116**, 2595–2602 (2019).

76. Rouyère, C., Serrano, T., Frémont, S. & Echard, A. Oxidation and reduction of actin: Origin, impact in vitro and functional consequences in vivo. *Eur. J. Cell Biol.* **101**, 151249 (2022).

77. Grintsevich, E. E. et al. F-actin dismantling through a redox-driven synergy between Mical and cofilin. *Nat. Cell Biol.* **18**, 876–885 (2016).

78. Grintsevich, E. E. et al. Catastrophic disassembly of actin filaments via Mical-mediated oxidation. *Nat. Commun.* **8**, 2183 (2017).
35. Gunsalus, K. C. et al. Mutations in twinstar, a Drosophila gene encoding a cofilin/ADF homologue, result in defects in centrosome migration and cytokinesis. *J. Cell Biol.* **131**, 1243–1259 (1995).

36. Somma, M. P., Fasulo, B., Cenci, G., Cundari, E. & Gatti, M. Molecular dissection of cytokinesis by RNA interference in Drosophila cultured cells. *Mol. Biol. Cell* **13**, 2448–2460 (2002).

37. Ono, K., Parast, M., Alberico, C., Benian, G. M. & Ono, S. Specific requirement for two ADF/cofilin isoforms in distinct actin-dependent processes in Caenorhabditis elegans. *J Cell Sci* **116**, 2073–2085 (2003).

38. Hotulainen, P., Paunola, E., Vartiainen, M. K. & Lappalainen, P. Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in mammalian nonmuscle cells. *Mol. Biol. Cell* **16**, 649–664 (2005).

39. Murthy, K. & Wadsworth, P. Myosin-II-dependent localization and dynamics of F-actin during cytokinesis. *Curr. Biol.*: CB **15**, 724–731 (2005).

40. Wiggan, O., Shaw, A. E., DeLuca, J. G. & Bamburg, J. R. ADF/cofilin regulates actomyosin assembly through competitive inhibition of myosin II binding to F-actin. *Dev. Cell* **22**, 530–543 (2012).

41. Xue, Z. & Sokac, A. M.- Back-to-back mechanisms drive actomyosin ring closure during Drosophila embryo cleavage. *J. Cell Biol.* **215**, 335–344 (2016).

42. Presle, A. et al. The viral restriction factor tetherin/BST2 tethers cytokinetic midbody remnants to the cell surface. *Curr. Biol.*: CB **31**, 2203–2213.e2205 (2021).

43. Nagaoka, R., Abe, H., Kusano, K. & Obinata, T. Concentration of cofilin, a small actin-binding protein, at the cleavage furrow during cytokinesis. *Cell Motil Cytoskeleton* **30**, 1–7 (1995).

44. Arber, S. et al. Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase. *Nature* **393**, 805–809 (1998).

45. Moriyama, K., Iida, K. & Yahara, I. Phosphorylation of Ser-3 of cofilin regulates its essential function on actin. *Genes Cells* **1**, 73–86 (1996).

46. Elam, W. A. et al. Phosphomimetic S3D cofilin binds but only weakly severs actin filaments. *J. Biol. Chem.* **292**, 19565–19579 (2017).

47. Wioland, H. et al. ADF/Cofilin Accelerates Actin Dynamics by Severing Filaments and Promoting Their Depolymerization at Both Ends. *Current biology*: CB **27**, 1956–1967.e1957 (2017).

48. Abe, H., Obinata, T., Minamide, L. S. & Bamburg, J. R. Xenopus laevis actin-depolymerizing factor/cofilin: a phosphorylation-regulated protein essential for development. *The J. Cell Biol.* **132**, 871–885 (1996).

49. Farrants, H. et al. Chemogenetic Control of Nanobodies. *Nat. Methods* **17**, 279–282 (2020).

50. Machesky, L. M. et al. Scar, a WASp-related protein, activates nucleation of actin filaments by the Arp2/3 complex. *Proc. Natl. Acad. Sci USA* **96**, 3739–3744 (1999).

51. Welch, M. D. & Way, M. Arp2/3-mediated actin-based motility: a tail of pathogen abuse. *Cell host microbe* **14**, 242–255 (2013).

52. Abella, J. V. et al. Isoform diversity in the Arp2/3 complex determines actin filament dynamics. *Nat. Cell Biol.* **18**, 76–86 (2016).

53. Gautreau, A. M., Fregoso, F. E., Simanov, G. & Dominguez, R. Nucleation, stabilization, and disassembly of branched actin networks. *Trends Cell Biol.* **32**, 421–432 (2022).

54. Lappalainen, P., Kotila, T., Jégou, A. & Romet-Lemonne, G. Biochemical and mechanical regulation of actin dynamics. *Nat. Rev. Mol. Cell Biol.* **23**, 836–852 (2022).

55. Wagner, A. R., Luan, Q., Liu, S. L. & Nolen, B. J. Dip1 defines a class of Arp2/3 complex activators that function without preformed actin filaments. *Curr. Biol.*: CB **23**, 1990–1998 (2013).

56. Cupido, T., Pisa, R., Kelley, M. E. & Kapoor, T. M. Designing a chemical inhibitor for the AAA protein spastin using active site mutations. *Nat. Chem. Biol.* **15**, 444–452 (2019).

57. Carlton, J. G., Caballe, A., Agromayor, M., Kloc, M. & Martin-Serrano, J. ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. *Science* **336**, 220–225 (2012).

58. Caballe, A. et al. ULK3 regulates cytokinetic abscission by phosphorylating ESCRT-III proteins. *eLife* **4**, e06547 (2015).

59. Christ, L. et al. ALIX and ESCRT-I/II function as parallel ESCRT-III recruiters in cytokinetic abscission. *J. Cell Biol.* **212**, 499–513 (2016).

60. Mierzwa, B. E. et al. Dynamic subunit turnover in ESCRT-III assemblies is regulated by Vps4 to mediate membrane remodelling during cytokinesis. *Nat. Cell Biol.* **19**, 787–798 (2017).

61. Chaigne, A. et al. Abscission Couples Cell Division to Embryonic Stem Cell Fate. *Dev. Cell* **5**, 195–208.e195 (2020).

62. Strohacker, L. K. et al. Identification of abscission checkpoint bodies as structures that regulate ESCRT factors to control abscission timing. *eLife* **10**, e63743 (2021).

63. Steigemann, P. et al. Aurora B-mediated abscission checkpoint protects against tetraploidization. *Cell* **136**, 473–484 (2009).

64. Kouranti, I., Sachse, M., Arouche, N., Goud, B. & Echard, A. Rab35 regulates an endocytic recycling pathway essential for the terminal steps of cytokinesis. *Curr. Biol.*: CB **16**, 1719–1725 (2006).

65. Mathieu, J. et al. Aurora B and cyclin B have opposite effects on the timing of cytokinesis abscission in Drosophila germ cells and in vertebrate somatic cells. *Dev. Cell* **26**, 250–265 (2013).

66. Wang, K., Wloka, C. & Bi, E. Non-muscle Myosin-II Is Required for the Generation of a Constriction Site for Subsequent Abscission. *iScience* **13**, 69–81 (2019).

67. Spector, I., Shochet, N. R., Blasberger, D. & Kashman, Y. Latrunculins–novel marine macrolides that disrupt microfilament organization and affect cell growth: I. Comparison with cytochalasin D. *Cell Motil. Cytoskeleton* **13**, 127–144 (1989).

68. Wolter, P. et al. GAS2L3, a target gene of the DREAM complex, is required for proper cytokinesis and genomic stability. *J. Cell Sci.* **125**, 2393–2406 (2012).

69. Pe'er, T. et al. Gas2l3, a novel constriction site-associated protein whose regulation is mediated by the APC/C Cdh1 complex. *PloS one* **8**, e57532 (2013).

70. Capalbo, L. et al. The midbody interactome reveals unexpected roles for PP1 phosphatases in cytokinesis. *Nat. Commun.* **10**, 4513 (2019).

71. Blanchoin, L., Pollard, T. D. & Mullins, R. D. Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks. *Curr. Biol.*: CB **10**, 1273–1282 (2000).

72. Prochniewicz, E., Janson, N., Thomas, D. D. & De la Cruz, E. M. Cofilin increases the torsional flexibility and dynamics of actin filaments. *J. Mol. Biol.* **353**, 990–1000 (2005).

73. Andrianantoandro, E. & Pollard, T. D. Mechanism of actin filament turnover by severing and nucleation at different concentrations of ADF/cofilin. *Mol. Cell* **24**, 13–23 (2006).

74. Chan, C., Beltzner, C. C. & Pollard, T. D. Cofilin dissociates Arp2/3 complex and branches from actin filaments. *Curr. Biol.*: CB **19**, 537–545 (2009).

75. Wioland, H., Jegou, A. & Romet-Lemonne, G. Torsional stress generated by ADF/cofilin on cross-linked actin filaments boosts their severing. *Proc. Natl. Acad. Sci. USA* **116**, 2595–2602 (2019).

76. Rouyère, C., Serrano, T., Frémont, S. & Echard, A. Oxidation and reduction of actin: Origin, impact in vitro and functional consequences in vivo. *Eur. J. Cell Biol.* **101**, 151249 (2022).

77. Grintsevich, E. E. et al. F-actin dismantling through a redox-driven synergy between Mical and cofilin. *Nat. Cell Biol.* **18**, 876–885 (2016).

78. Grintsevich, E. E. et al. Catastrophic disassembly of actin filaments via Mical-mediated oxidation. *Nat. Commun.* **8**, 2183 (2017).
79. Wioland, H. et al. Actin filament oxidation by MICAL1 suppresses protections from cofilin-induced disassembly. *EMBO Rep.* **22**, e50965 (2021).

80. Ortica, S., Tarantino, N., Aulner, N., Israël, A. & Gupta-Rossi, N. The 4 Notch receptors play distinct and antagonistic roles in the pro-liferation and hepatocytic differentiation of liver progenitors. *Faseb J* **28**, 603–614 (2014).

81. Obrdlik, A. & Percipalle, P. The F-actin severing protein cofilin-1 is required for RNA polymerase II transcription elongation. *Nucleus* **2**, 72–79 (2011).

82. Lacroix, B. et al. Tubulin polyglutamylation stimulates spastin-mediated microtubule severing. *J.Cell Biol.* **189**, 945–954 (2010).

## Acknowledgements

We thank G. Romet-Lemonne, J. Mathieu, Antoine Jegou and the Echard Lab members N. Gupta-Rossi and M. Serres for critical reading of the manuscript; N. Gupta-Rossi and N. Sassoon for BMEL cells; Quentin Gaia Gianetto for Supplementary Fig. 1a; A. Gautreau and T. Kapoor for reagents; K. Johnsson for kindly sharing reagents before publications; and the Recombinant antibodies platform (TAb-IP, Institut Curie, Paris) for antibodies. We thank PH. Commere from the Utechs CB, Institut Pasteur for FACS sorting. This work has been supported by Institut Pasteur, CNRS, ANR (Cytosign, RedoxActin) and Fondation pour le Recherche Médicale: Recherche soutenue par la FRM EQU202103012627 to A.E. T.A. received a post-doctoral fellowship from Fondation pour le Recherche Médicale (FRM SPF201809006907).

## Author contributions

T.A. conceived, carried out and analyzed the experiments presented in Figs. 1, 2, 3, 4, 5, 6, 7 and Supplementary Fig. 1, 2, 3, 4, 5, 6; S.F. obtained preliminary results on Cofilin-1 localization; A.E. conceived and supervised the project; A.E. secured funding; T.A. and A.E. wrote the manuscript.

## Competing interests

The authors declare no competing interests.

## Additional information

**Supplementary information** The online version contains supplementary material available at
https://doi.org/10.1038/s41467-024-46062-9.

**Correspondence** and requests for materials should be addressed to Arnaud Echard.

**Peer review information** *Nature Communications* thanks the anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.

**Reprints and permissions information** is available at
http://www.nature.com/reprints

**Publisher's note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

**Open Access** This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

© The Author(s) 2024
79. Wioland, H. et al. Actin filament oxidation by MICAL1 suppresses protections from cofilin-induced disassembly. *EMBO Rep.* **22**, e50965 (2021).

80. Ortica, S., Tarantino, N., Aulner, N., Israël, A. & Gupta-Rossi, N. The 4 Notch receptors play distinct and antagonistic roles in the pro-liferation and hepatocytic differentiation of liver progenitors. *Faseb J* **28**, 603–614 (2014).

81. Obrdlik, A. & Percipalle, P. The F-actin severing protein cofilin-1 is required for RNA polymerase II transcription elongation. *Nucleus* **2**, 72–79 (2011).

82. Lacroix, B. et al. Tubulin polyglutamylation stimulates spastin-mediated microtubule severing. *J.Cell Biol.* **189**, 945–954 (2010).

## Acknowledgements

We thank G. Romet-Lemonne, J. Mathieu, Antoine Jegou and the Echard Lab members N. Gupta-Rossi and M. Serres for critical reading of the manuscript; N. Gupta-Rossi and N. Sassoon for BMEL cells; Quentin Gaia Gianetto for Supplementary Fig. 1a; A. Gautreau and T. Kapoor for reagents; K. Johnsson for kindly sharing reagents before publications; and the Recombinant antibodies platform (TAb-IP, Institut Curie, Paris) for antibodies. We thank PH. Commere from the Utechs CB, Institut Pasteur for FACS sorting. This work has been supported by Institut Pasteur, CNRS, ANR (Cytosign, RedoxActin) and Fondation pour le Recherche Médicale: Recherche soutenue par la FRM EQU202103012627 to A.E. T.A. received a post-doctoral fellowship from Fondation pour le Recherche Médicale (FRM SPF201809006907).

## Author contributions

T.A. conceived, carried out and analyzed the experiments presented in Figs. 1, 2, 3, 4, 5, 6, 7 and Supplementary Fig. 1, 2, 3, 4, 5, 6; S.F. obtained preliminary results on Cofilin-1 localization; A.E. conceived and supervised the project; A.E. secured funding; T.A. and A.E. wrote the manuscript.

## Competing interests

The authors declare no competing interests.

## Additional information

**Supplementary information** The online version contains supplementary material available at
https://doi.org/10.1038/s41467-024-46062-9.

**Correspondence** and requests for materials should be addressed to Arnaud Echard.

**Peer review information** *Nature Communications* thanks the anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.

**Reprints and permissions information** is available at
http://www.nature.com/reprints

**Publisher's note** Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

**Open Access** This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

© The Author(s) 2024